: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Vaccines

Free Subscription

Articles published in Vaccine
Retrieve available abstracts of 1073 articles:
HTML format

Single Articles

November 2022

TSURANE K, Umehara N, Nakayama T, Okada K, et al
Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society.
Vaccine. 2022;40:7122-7129.
PubMed Abstract available

CAETANO C, Morgado ML, Patricio P, Leite A, et al
Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal.
Vaccine. 2022;40:7115-7121.
PubMed Abstract available

MARCHETTI F, Lamiani G, Bona M, Amerighi C, et al
Developing communication tools on rotavirus vaccination to support family paediatricians in Italy.
Vaccine. 2022;40:7108-7114.
PubMed Abstract available

KAUFMANN J, DeVoe JE, Angier H, Moreno L, et al
Association of parent influenza vaccination and early childhood vaccinations using linked electronic health record data.
Vaccine. 2022;40:7097-7107.
PubMed Abstract available

HASSAN YAM, Daud Ali M, Al-Eid RR, Al-Ghuraya FA, et al
A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
Vaccine. 2022;40:7087-7096.
PubMed Abstract available

FRANCO C, Herazo-Padilla N, Castaneda JA
A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia.
Vaccine. 2022;40:7073-7086.
PubMed Abstract available

ZHOU W, Tang B, Bai Y, Shao Y, et al
The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.
Vaccine. 2022;40:7141-7150.
PubMed Abstract available

MATHEWS KO, Norris JM, Phalen D, Malikides N, et al
Factors associated with Q fever vaccination in Australian wildlife rehabilitators.
Vaccine. 2022 Nov 21:S0264-410X(22)01364-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TRAN QM, Soda J, Siraj A, Moore S, et al
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling.
Vaccine. 2022 Nov 21:S0264-410X(22)01426-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SEEGER JD, Amend KL, Turnbull BR, Zhou L, et al
Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States.
Vaccine. 2022 Nov 21:S0264-410X(22)01307-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

UTAZI CE, Aheto JMK, Wigley A, Tejedor-Garavito N, et al
Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
Vaccine. 2022 Nov 19:S0264-410X(22)01420-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FEKETE M, Horvath A, Santa B, Tomisa G, et al
COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease - A cross-sectional study in Hungary.
Vaccine. 2022 Nov 18:S0264-410X(22)01415-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ZHANG Z, Shi J, Zhang X, Guo X, et al
Willingness of parents of 9-to-18-year-old females in China to vaccinate their daughters with HPV vaccine.
Vaccine. 2022 Nov 18:S0264-410X(22)01404-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

NOVAK A, Hindriks E, Hoek A, Veraart C, et al
Cellular and humoral immune responsiveness to inactivated Leptospira interrogans in dogs vaccinated with a tetravalent Leptospira vaccine.
Vaccine. 2022 Nov 18:S0264-410X(22)01417-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

NIQUEUX E, Flodrops M, Allee C, Lebras MO, et al
Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks.
Vaccine. 2022 Nov 18:S0264-410X(22)01398-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

AMPOFO AG, Mackenzie L, Boyes AW
HPV vaccination: Intention to participate among female senior high school students in Ghana.
Vaccine. 2022 Nov 18:S0264-410X(22)01383-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KIM J, Kim ED, Shin HS, Han SJ, et al
Effectiveness and safety of injectable human papilloma virus vaccine administered as eyedrops.
Vaccine. 2022 Nov 16:S0264-410X(22)01192-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KALKOWSKA DA, Wassilak SGF, Pallansch MA, Burns CC, et al
Outbreak response strategies with type 2-containing oral poliovirus vaccines.
Vaccine. 2022 Nov 16:S0264-410X(22)01336-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

POURIAYEVALI MH, Teimoori A, Esmaeili S, Abdoli A, et al
Corrigendum to "Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein" [Vaccine 40(20) (2022) 2856-2868].
Vaccine. 2022;40:7009.
PubMed

PANICKAN S, Bhatia S, Bhat S, Bhandari N, et al
Reverse genetics based H5N2 vaccine provides clinical protection against H5N1, H5N8 and H9N2 avian influenza infection in chickens.
Vaccine. 2022;40:6998-7008.
PubMed Abstract available

ALFANO V, Ercolano S
Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination?
Vaccine. 2022;40:6987-6997.
PubMed Abstract available

TURBYFILL C, Adams K, Tenforde MW, Murray NL, et al
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
Vaccine. 2022;40:6979-6986.
PubMed Abstract available

KULKARNI AV, Jaggaiahgari S, Iyengar S, Simhadri V, et al
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients.
Vaccine. 2022;40:6971-6978.
PubMed Abstract available

MOORE KL, Tan L
Preferential recommendations for vaccines: Time for a structured, transparent process.
Vaccine. 2022;40:6893-6894.
PubMed

HE H, Zhu Y, Jin M, Zhou Y, et al
The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study.
Vaccine. 2022;40:6956-6962.
PubMed Abstract available

ATTWELL K, Rizzi M, Paul KT
Consolidating a research agenda for vaccine mandates.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01384.
PubMed Abstract available

HANSEN J, Yee A, Lewis N, Li S, et al
Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01395.
PubMed Abstract available

MANANDHAR P, Wannemuehler K, Danovaro-Holliday MC, Nic Lochlainn L, et al
Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01301.
PubMed Abstract available

FIX J, Vielot NA, Lund JL, Weber DJ, et al
Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50-64 years old in the United States.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01347.
PubMed Abstract available

ZIMMERMAN T, Shiroma K, Fleischmann KR, Xie B, et al
Misinformation and COVID-19 vaccine hesitancy.
Vaccine. 2022 Nov 14:S0264-410X(22)01402-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

VANWORMER JJ, Alicea G, Weichelt BP, Berg RL, et al
COVID-19 vaccine coverage disparities in rural and farm children.
Vaccine. 2022 Nov 14:S0264-410X(22)01403-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FABIANI M, Mateo-Urdiales A, Sacco C, Rota MC, et al
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study.
Vaccine. 2022 Nov 14:S0264-410X(22)01399-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

JACKSON ML, Phillips CH, Wellwood S, Kiniry E, et al
Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons.
Vaccine. 2022 Nov 12. pii: S0264-410X(22)01397.
PubMed Abstract available

KPOZEHOUEN EB, Tan T, Macintyre CR
Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation.
Vaccine. 2022 Nov 12. pii: S0264-410X(22)01377.
PubMed Abstract available

QI W, Qingfeng L, Jing Z, Maolin Z, et al
A novel multi-epitope vaccine of HPV16 E5E6E7 oncoprotein delivered by HBc VLPs induced efficient prophylactic and therapeutic antitumor immunity in tumor mice model.
Vaccine. 2022 Nov 11. pii: S0264-410X(22)01327.
PubMed Abstract available

LUKEHART SA, Molini B, Gomez A, Godornes C, et al
Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum.
Vaccine. 2022 Nov 11. pii: S0264-410X(22)01372.
PubMed Abstract available

DE FIGUEIREDO A, Simas C, Larson HJ
COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: A multi-country cross-sectional study.
Vaccine. 2022 Nov 10:S0264-410X(22)01310-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

YU Z, Keskinocak P, Sokol J, Chen YH, et al
Flexible analytic model to inform multi-stakeholder pediatric vaccine scheduling decisions.
Vaccine. 2022 Nov 9. pii: S0264-410X(22)01198.
PubMed Abstract available

BAI Q, Wang Z, An Y, Tian J, et al
Chitosan-functionalized graphene oxide as adjuvant in HEV P239 vaccine.
Vaccine. 2022 Nov 9. pii: S0264-410X(22)01375.
PubMed Abstract available

YU X, Suo L, Li W, Chen W, et al
Molecular surveillance of rubella virus in Beijing, China during 2010-2021: Progress and challenges in rubella elimination.
Vaccine. 2022;40:6857-6863.
PubMed Abstract available

REN H, Li H, Cao L, Wang Z, et al
Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice.
Vaccine. 2022;40:6830-6838.
PubMed Abstract available

ECHEVERRIA-LONDONO S, Hartner AM, Li X, Roth J, et al
Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.
Vaccine. 2022;40:6806-6817.
PubMed Abstract available

MARTINI M, Orsini D
The fight against poliomyelitis through the history: past, present and hopes for the future. Albert Sabin's missing Nobel and his "gift to all the world's children".
Vaccine. 2022;40:6802-6805.
PubMed Abstract available

TRENTELMAN JJA, de Vogel FA, Colstrup E, Sima R, et al
Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins.
Vaccine. 2022 Nov 8. pii: S0264-410X(22)01292.
PubMed Abstract available

MARSHALL T, Addison M, Crawford NW, Buttery JP, et al
Aiming too high: Shoulder injury related to vaccine administration (SIRVA): A case series.
Vaccine. 2022 Nov 8. pii: S0264-410X(22)01368.
PubMed Abstract available

HASHIMOTO M, Aoe S, Kawazu Y, Seki NM, et al
Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques.
Vaccine. 2022 Nov 8. pii: S0264-410X(22)01379.
PubMed Abstract available

MOLL K, Lufkin B, Fingar KR, Ke Zhou C, et al
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.
Vaccine. 2022 Nov 8:S0264-410X(22)01373-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

LOPEZ-DORIGA RUIZ P, Gunnes N, Michael Gran J, Karlstad O, et al
Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01367.
PubMed Abstract available

KIRTLAND KA, Raghunathan T, Patel Murthy B, Li J, et al
Estimating vaccination coverage for routinely recommended vaccines among children aged 24months and adolescents aged 13 through 17years using data from immunization information systems in the United States.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01341.
PubMed Abstract available

OSOWICKI J, Morgan HJ, Harris A, Clothier HJ, et al
Guillain-Barre syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01366.
PubMed Abstract available

HAO XB, Anand M, Wang TR, Rao AR, et al
Reducing COVID vaccine hesitancy by inducing a comparative mindset.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01359.
PubMed Abstract available

BEALE S, Burns R, Braithwaite I, Byrne T, et al
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01362.
PubMed Abstract available

SKAWRAN S, Schiesser H, Maurer A, Sartoretti T, et al
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01376.
PubMed Abstract available

WU YY, Zhang W
Demographic disparities in COVID-19 vaccine hesitancy among U.S. adults: Analysis of household pulse survey data from Jul 21 to Oct 11 in 2021.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01381.
PubMed Abstract available

TAKEUCHI Y, Iwagami M, Ono S, Michihata N, et al
A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01370.
PubMed Abstract available

GUERIN RJ, Naeim A, Baxter-King R, Okun AH, et al
Parental intentions to vaccinate children against COVID-19: Findings from a U.S. National Survey.
Vaccine. 2022 Nov 7:S0264-410X(22)01371-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

GHIANI M, Hagemann C, Friedrich J, Maywald U, et al
Can risk area designation help increase vaccination coverage for Tick-Borne Encephalitis? Evidence from German claims data.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01346.
PubMed Abstract available

LEUNG J, Gray EB, Anderson TC, Sharkey SM, et al
Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01328.
PubMed Abstract available

THOMMES E, Coudeville L, Muhammad R, Martin M, et al
Public health impact and cost-effectiveness of implementing a 'pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01343.
PubMed Abstract available

KRASSELT J, Robin D, Fadda M, Geutjes A, et al
Tick-Talk: Parental online discourse about TBE vaccination.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01326.
PubMed Abstract available

PRIYAMVADA L, Carson WC, Ortega E, Navarra T, et al
Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
Vaccine. 2022 Nov 4. pii: S0264-410X(22)01360.
PubMed Abstract available

MORSTEAD T, Zheng J, Sin NL, DeLongis A, et al
Perceived threat and coping responses during the COVID-19 pandemic: Prospective associations with vaccine hesitancy.
Vaccine. 2022 Nov 4. pii: S0264-410X(22)01363.
PubMed Abstract available

RICKS T, Trent MJ, MacIntyre CR
Predictors of herpes zoster vaccination among Australian adults aged 65 and over.
Vaccine. 2022 Nov 3. pii: S0264-410X(22)01332.
PubMed Abstract available

WATESKA AR, Patricia Nowalk M, Lin CJ, Harrison LH, et al
Cost-effectiveness of revised US pneumococcal vaccination recommendations in underserved minority adults < 65-years-old.
Vaccine. 2022 Nov 3. pii: S0264-410X(22)01340.
PubMed Abstract available

MALDEN DE, Gee J, Glenn S, Li Z, et al
Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system.
Vaccine. 2022 Nov 3. pii: S0264-410X(22)01361.
PubMed Abstract available

KURATA T, Miyama T, Kanbayashi D, Kaida Y, et al
Increasing seroprevalence but waning herd immunity against measles after elimination: Longitudinal seroepidemiology of measles in Osaka Prefecture, Japan, 2003-2020.
Vaccine. 2022;40:6581-6588.
PubMed Abstract available

HAYMAN B, Kumar Suri R, Downham M
Sustainable vaccine manufacturing in low- and middle-Income countries.
Vaccine. 2022 Nov 2. pii: S0264-410X(22)01305.
PubMed Abstract available

FISHER DG, Gnazzo V, Holthausen DJ, Lopez CB, et al
Non-standard viral genome-derived RNA activates TLR3 and type I IFN signaling to induce cDC1-dependent CD8+ T-cell responses during vaccination in mice.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01312.
PubMed Abstract available

CAREY KA, Newman LM, Spicknall IH
Estimating the population level impact of a gonococcal vaccine candidate: Predictions from a simple mathematical model.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01291.
PubMed Abstract available

MORRILL JC, Peters CJ, Bettinger GE, Palermo PM, et al
Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01339.
PubMed Abstract available

TOMPKINS LK, Baggs J, Myers TR, Gee JM, et al
Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01342.
PubMed Abstract available

CHANG CT, Lim XJ, Chew CC, Rajan P, et al
Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01334.
PubMed Abstract available

October 2022

KUNASEKARAN M, Moa A, Hooshmand E, Trent M, et al
Effectiveness estimates for enhanced trivalent influenza vaccines in an aged care summer outbreak.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)00766.
PubMed Abstract available

KUNASEKARAN M, Poulos CJ, Chughtai AA, Heslop DJ, et al
Factors associated with repeated influenza vaccine uptake among aged care staff in an Australian sample from 2017 to 2019.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)00981.
PubMed Abstract available

TONG C, Liu H, Wang J, Sun Y, et al
Safety, efficacy, and DIVA feasibility on a novel live attenuated CSFV marker vaccine candidate.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01293.
PubMed Abstract available

THULUVA S, Paradkar V, Gunneri S, Yerroju V, et al
Safety, tolerability and immunogenicity of Biological E's CORBEVAX vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01308.
PubMed Abstract available

LIMAYE RJ, Paul A, Gur-Arie R, Zavala E, et al
A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01331.
PubMed Abstract available

CAPURRO G, Maier R, Tustin J, Jardine CG, et al
"They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01338.
PubMed Abstract available

SIANI A, Tranter A
Is vaccine confidence an unexpected victim of the COVID-19 pandemic?
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01337.
PubMed Abstract available

MARIE REINHART A, Tian Y, Lilly AE
The role of trust in COVID-19 vaccine hesitancy and acceptance among Black and White Americans.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01330.
PubMed Abstract available

CRUZ MC, Nascimento-Carvalho CM
The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01335.
PubMed Abstract available

GILLES C, Rozenberg S, Buxant F, Manigart Y, et al
HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01288.
PubMed Abstract available

XIE L, Li Y
Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development.
Vaccine. 2022 Oct 29. pii: S0264-410X(22)01311.
PubMed Abstract available

HEYERDAHL LW, Dielen S, Dodion H, Van Riet C, et al
Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patients.
Vaccine. 2022 Oct 27. pii: S0264-410X(22)01306.
PubMed Abstract available

BAMOUH Z, Hamdi J, Elkarhat Z, Fellahi S, et al
Attenuation and genetic characteristics of a Moroccan strain of Camel pox virus.
Vaccine. 2022;40:6471-6480.
PubMed Abstract available

SCHIFF J, Schmidt AR, Pham PK, Perez JB, et al
Parental attitudes in the pediatric emergency department about the COVID-19 vaccine.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01309.
PubMed Abstract available

MALTEZOU HC, Ledda C, Gagneux-Brunon A, Botelho-Nevers E, et al
Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01313.
PubMed

MALTEZOU HC, Gamaletsou MN, Koukou DM, Giannouchos TV, et al
Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01304.
PubMed Abstract available

TADDIO A, McMurtry CM, Logeman C, Gudzak V, et al
Prevalence of pain and fear as barriers to vaccination in children - Systematic review and meta-analysis.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01287.
PubMed Abstract available

PHOKSAWAT W, Nithichanon A, Lerdsamran H, Wongratanacheewin S, et al
Phenotypic and functional changes of T cell subsets after CoronaVac vaccination.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01265.
PubMed Abstract available

SHU Y, Yu Y, Ji Y, Zhang L, et al
Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20-45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01281.
PubMed Abstract available

SERRA L, Webber C, Burman C, Bueti P, et al
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01197.
PubMed Abstract available

RABE APJ, Costello P, Were JJ, Farrer A, et al
The burden of selected vaccine-preventable diseases on the secondary care health system in England: Results from a five-year administrative healthcare dataset.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01263.
PubMed Abstract available

MADEWELL ZJ, Chacon-Fuentes R, Badilla-Vargas X, Ramirez C, et al
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01284.
PubMed Abstract available

NAYAR R, Pattath B, Mantha N, Debnath S, et al
Routine childhood vaccination in India from 2005-2006 to 2015-2016: Temporal trends and geographic variation.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01285.
PubMed Abstract available

ARASA J, Lopez-Lacort M, Diez-Domingo J, Orrico-Sanchez A, et al
Impact of rotavirus vaccination on seizure hospitalizations in children: A systematic review.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01228.
PubMed Abstract available

ARRIETA A, Garcia-Prado A, Sarmiento JP, Paz Castro C, et al
Identifying early adopters of COVID-19 vaccines in Latin America.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01294.
PubMed Abstract available

SUN R, Budhwani H
Negative sentiments toward novel coronavirus (COVID-19) vaccines.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01297.
PubMed Abstract available

BLANCO S, Spinsanti L, Javier Aguilar J, Diaz A, et al
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01283.
PubMed Abstract available

SANTIBANEZ TA, Black CL, Vogt TM, Chatham-Stephens K, et al
Where are children ages 5-17 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01282.
PubMed Abstract available

STONER MCD, Tweedy D, Comello MGL, Toval C, et al
Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01286.
PubMed Abstract available

DUCLOS P, MacDonald NE, Dochez C, Thacker N, et al
Report of the 2nd workshop of the International Collaboration on advanced vaccinology training.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01222.
PubMed Abstract available

ZHONG VW, Li X, Ran J, Hu G, et al
Vaccination, symptomatic infection and negative conversion of viral RNA by body mass index, diabetes, and age: An observational study.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01262.
PubMed Abstract available

HOSHI SL, Shono A, Seposo X, Okubo R, et al
Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01259.
PubMed Abstract available

LAI L, Rouphael N, Xu Y, Kabbani S, et al
An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cTFH) cells and antibody responses.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01146.
PubMed Abstract available

HALL PA, Meng G, Sakib MN, Quah ACK, et al
Do the vaccinated perform less distancing, mask wearing and hand hygiene? A test of the risk compensation hypothesis in a representative sample during the COVID-19 pandemic.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01289.
PubMed Abstract available

FUJI N, Pichichero M, Kaur R
Pathogenesis of Streptococcus pneumoniae serotype 3 during natural colonization and infections among children and its IgG correlate of protection in a mouse model.
Vaccine. 2022;40:6412-6421.
PubMed Abstract available

RUAN J, Dong W, Liu Y, Zhang Y, et al
Establishment of a model to assess mumps virus neurovirulence in neonatal Wistar rats.
Vaccine. 2022;40:6397-6403.
PubMed Abstract available

GOLLAMUDI J, Sartain SE, Navaei AH, Aneja S, et al
Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2022;40:6431-6444.
PubMed Abstract available

SAPUAN S, Andrews N, Hallis B, Hole L, et al
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containin
Vaccine. 2022 Oct 19. pii: S0264-410X(22)01243.
PubMed Abstract available

PENG M, Joo J, Alvarado-Martinez Z, Tabashsum Z, et al
Intracellular autolytic whole cell Salmonella vaccine prevents colonization of pathogenic Salmonella Typhimurium in chicken.
Vaccine. 2022 Oct 19. pii: S0264-410X(22)01261.
PubMed Abstract available

URUENA A, Ruiz JI, Lew DA, David J, et al
Opinions, attitudes, and barriers to pediatric vaccination in Argentina.
Vaccine. 2022 Oct 19. pii: S0264-410X(22)01256.
PubMed Abstract available

LIAO SH, Chang WJ, Hsu CY, Ming-Fang Yen A, et al
Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01258.
PubMed Abstract available

AKSOY N, Ozturk N, Ulusoy S, Omur MF, et al
Knowledge and attitude of students studying at health department towards HPV and HPV vaccination.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01264.
PubMed Abstract available

TAKAHASHI Y, Ishitsuka K, Sampei M, Okawa S, et al
COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01227.
PubMed Abstract available

RHODES S, Smith N, Evans T, White R, et al
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01260.
PubMed Abstract available

CREISHER PS, Campbell AD, Perry JL, Roznik K, et al
Influenza subtype-specific maternal antibodies protect offspring against infection but inhibit vaccine-induced immunity and protection in mice.
Vaccine. 2022 Oct 14. pii: S0264-410X(22)01241.
PubMed Abstract available

HUDSON A, Hall PA, Hitchman SC, Meng G, et al
Cognitive predictors of COVID-19 mitigation behaviors in vaccinated and unvaccinated general population members.
Vaccine. 2022 Oct 13. pii: S0264-410X(22)01242.
PubMed Abstract available

AROCHO ROSARIO CM, Miller RJ, Klafke GM, Coates C, et al
Interaction between anti-tick vaccine and a macrocyclic lactone improves acaricidal efficacy against Rhipicephalus (Boophilus) microplus (Canestrini) (Acari: Ixodidae) in experimentally infested cattle.
Vaccine. 2022 Oct 13. pii: S0264-410X(22)01230.
PubMed Abstract available

SAADE EA, Abul Y, McConeghy K, Edward Davidson H, et al
High-dose influenza vaccines for the prevention of hospitalization due to cardiovascular events in older adults in the nursing home: Post-hoc analysis of a cluster-randomized trial.
Vaccine. 2022 Oct 13. pii: S0264-410X(22)01215.
PubMed Abstract available

MO Y, Li Y, Liu G, Chen J, et al
A phase II, single-center, randomized, double-blind, parallel control clinical study evaluating the immunogenicity and safety of a two-dose schedule of serogroups ACYW meningococcal polysaccharide conjugate vaccine.
Vaccine. 2022 Oct 12. pii: S0264-410X(22)00948.
PubMed Abstract available

LIU S, Yang G, Li M, Sun F, et al
Transcutaneous immunization via dissolving microneedles protects mice from lethal influenza H7N9 virus challenge.
Vaccine. 2022 Oct 12. pii: S0264-410X(22)01102.
PubMed Abstract available

WHALEY M, Axon DR
Factors associated with pneumococcal vaccine uptake among vulnerable older adults in the United States primary care setting.
Vaccine. 2022 Oct 10. pii: S0264-410X(22)01229.
PubMed Abstract available

BUDDY CREECH C, Jimenez-Truque N, Kown N, Sokolow K, et al
Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults.
Vaccine. 2022 Oct 8. pii: S0264-410X(22)01196.
PubMed Abstract available

VOGELSANG EM, Polonijo AN
Scarier than the flu shot? : The social determinants of shingles and influenza vaccinations among U.S. older adults.
Vaccine. 2022 Oct 8. pii: S0264-410X(22)01183.
PubMed Abstract available

CHONG CY, Tan NW, Yung CF, Li J, et al
Effectiveness of maternal pertussis vaccination in Singapore: A test-negative case-control study.
Vaccine. 2022 Oct 8. pii: S0264-410X(22)01219.
PubMed Abstract available

RUGHINIS C, Vulpe SN, Flaherty MG, Vasile S, et al
Shades of doubt: Measuring and classifying vaccination confidence in Europe.
Vaccine. 2022 Oct 7. pii: S0264-410X(22)01147.
PubMed Abstract available

CHEN JY, Hsieh SM, Hwang SJ, Liu CS, et al
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study.
Vaccine. 2022 Oct 7. pii: S0264-410X(22)01200.
PubMed Abstract available

RUSTANDI RR, Hamm M, Onimus M, Yuan Y, et al
Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB(R) by capillary electrophoresis and NMR spectroscopy.
Vaccine. 2022;40:6012-6016.
PubMed Abstract available

KATZ S, Townsend-Payne K, Louth J, Lee-Jones L, et al
Validation and use of a serum bactericidal antibody assay for Neisseria meningitidis serogroup X in a seroprevalence study in Niger, West Africa.
Vaccine. 2022;40:6042-6047.
PubMed Abstract available

MARLOWE E, Pranikoff S, Borsheim B, Salafian K, et al
Pilot study to determine effect of an altruism intervention focusing on herd immunity to enhance influenza vaccination rates.
Vaccine. 2022 Oct 6. pii: S0264-410X(22)01194.
PubMed Abstract available

KRAAY ANM, Steele MK, Baker JM, Hall EW, et al
Predicting the long-term impact of rotavirus vaccination in 112 countries from 2006 to 2034: A transmission modeling analysis.
Vaccine. 2022 Oct 6. pii: S0264-410X(22)01193.
PubMed Abstract available

WOLF AS, Mitsi E, Jones S, Jochems SP, et al
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation.
Vaccine. 2022 Oct 6. pii: S0264-410X(22)01190.
PubMed Abstract available

BYRNE A, Thompson LA, Filipp SL, Ryan K, et al
COVID-19 vaccine perceptions and hesitancy amongst parents of school-aged children during the pediatric vaccine rollout.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01221.
PubMed Abstract available

SIMON JK, Kennedy SB, Mahon BE, Dubey SA, et al
Immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01145.
PubMed Abstract available

PAGUIO JA, Ojikutu BO, Alfonso PG, Yao JS, et al
Association of culturally competent care with influenza vaccination coverage in the United States.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01065.
PubMed Abstract available

CHUGHTAI AA, Mohammed S, Al Ariqi L, McCarron M, et al
Development of a road map to scale up the uptake and utilization of influenza vaccine in 22 countries of Eastern Mediterranean Region.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01159.
PubMed Abstract available

VAN EWIJK CE, Hazelhorst EI, Hahne SJM, Knol MJ, et al
COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign.
Vaccine. 2022 Oct 4. pii: S0264-410X(22)01213.
PubMed Abstract available

AL-SHAIKH A, Mahmoud RI, Boukerdenna H, Muthu N, et al
Counselling of non-communicable diseases' patients for COVID-19 vaccine uptake in Jordan: Evaluating the intervention.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01214.
PubMed Abstract available

FERREIRA LS, de Almeida GB, Borges ME, Simon LM, et al
Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01216.
PubMed Abstract available

CHAO CR, Xu L, Cannizzaro N, Bronstein D, et al
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01195.
PubMed Abstract available

ODIO CD, Katzelnick LC
'Mix and Match' vaccination: Is dengue next?
Vaccine. 2022 Oct 1. pii: S0264-410X(22)01101.
PubMed Abstract available

September 2022

MANJATE F, Quinto L, Chirinda P, Acacio S, et al
Impact of rotavirus vaccination on diarrheal hospitalizations in children younger than 5 years of age in a rural southern Mozambique.
Vaccine. 2022 Sep 30. pii: S0264-410X(22)01158.
PubMed Abstract available

NAKASHIMA K, Suzuki K, Aoshima M, Murabata M, et al
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study
Vaccine. 2022 Sep 29. pii: S0264-410X(22)01163.
PubMed Abstract available

SILVA-VALENCIA J, Soto-Becerra P, Escobar-Agreda S, Fernandez-Navarro M, et al
Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study usi
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01189.
PubMed Abstract available

TRAKARNVANICH T, Ngamvichchukorn T, Phumisantiphong U, Pholtawornkulchai K, et al
Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01187.
PubMed Abstract available

MERDRIGNAC L, Acosta L, Habington A, Garcia Cenoz M, et al
Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01160.
PubMed Abstract available

SPETZ M, Lundberg L, Nwaru C, Li H, et al
An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01186.
PubMed Abstract available

HATHAWAY CA, Siegel EM, Gonzalez BD, Oswald LB, et al
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01184.
PubMed Abstract available

MARCHESE AM, Beyhaghi H, Orenstein WA
With established safe and effective use, protein vaccines offer another choice against COVID-19.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01185.
PubMed

CERVANTES-TORRES J, Rosales-Mendoza S, Cabello C, Montero L, et al
Towards the development of an epitope-focused vaccine for SARS-CoV-2.
Vaccine. 2022 Sep 27. pii: S0264-410X(22)01168.
PubMed Abstract available

LLOYD PC, Hu M, Wong HL, Shoaibi A, et al
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.
Vaccine. 2022 Sep 27. pii: S0264-410X(22)01167.
PubMed Abstract available

ZHU H, Li X, Ren X, Chen H, et al
Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01165.
PubMed Abstract available

OHTA M, Kambayashi Y, Mita H, Kuroda T, et al
Protective efficacy of a reverse genetics-derived inactivated vaccine against equine influenza virus in horses.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01155.
PubMed Abstract available

STOFFEL ST, Colaninno A, Bram R, Schwenkglenks M, et al
Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB).
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01164.
PubMed Abstract available

TOLSTRUP WESTER C, Lybecker Scheel-Hincke L, Bovil T, Andersen-Ranberg K, et al
Prayer frequency and COVID-19 vaccine hesitancy among older adults in Europe.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01153.
PubMed Abstract available

GATES DM, Cohen SA, Orr K, Caffrey AR, et al
Pediatric influenza vaccination rates lower than previous estimates in the United States.
Vaccine. 2022 Sep 24. pii: S0264-410X(22)01162.
PubMed Abstract available

NOMURA Y, Noda K, Oohashi Y, Okuda S, et al
Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan.
Vaccine. 2022 Sep 24. pii: S0264-410X(22)01144.
PubMed Abstract available

MUES KE, Kirk B, Patel DA, Gelman A, et al
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States.
Vaccine. 2022 Sep 23. pii: S0264-410X(22)01120.
PubMed Abstract available

POLAND GA
The human immune response to vaccines is symphonic, polyphonic, homophonic, and megaphonic.
Vaccine. 2022 Sep 23. pii: S0264-410X(22)01099.
PubMed

MOHAMMED AH, Hassan BAR, Wayyes AM, Gadhban AQ, et al
Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East.
Vaccine. 2022 Sep 23. pii: S0264-410X(22)01161.
PubMed Abstract available

KUIPER VP, van der Plas P, Hoogerwerf MA, Pieter R Koopman J, et al
A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease.
Vaccine. 2022 Sep 22. pii: S0264-410X(22)01100.
PubMed Abstract available

RUCKSTUHL L, Czock A, Haile SR, Lang P, et al
Influence of cantonal health policy frameworks & activities on the influenza vaccination rate in patients with non-communicable diseases in Switzerland.
Vaccine. 2022 Sep 22. pii: S0264-410X(22)01148.
PubMed Abstract available

ROMER D, Winneg KM, Jamieson PE, Brensinger C, et al
Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5-11-year-olds in the United States.
Vaccine. 2022 Sep 22. pii: S0264-410X(22)01154.
PubMed Abstract available

KIEFER MK, Mehl R, Rood KM, Germann K, et al
Association between social vulnerability and COVID-19 vaccination hesitancy and vaccination in pregnant and postpartum individuals.
Vaccine. 2022 Sep 21. pii: S0264-410X(22)01152.
PubMed Abstract available

DYSON EH, Simpson AJH, Gwyther RJ, Cuthbertson H, et al
Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses.
Vaccine. 2022 Sep 21. pii: S0264-410X(22)01045.
PubMed Abstract available

LIU B, Gidding H, Stepien S, Cretikos M, et al
Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection.
Vaccine. 2022 Sep 21. pii: S0264-410X(22)01126.
PubMed Abstract available

FENG T, Li M, Zhang L, Li S, et al
Immunity of two novel hepatitis C virus polyepitope vaccines.
Vaccine. 2022 Sep 20. pii: S0264-410X(22)01115.
PubMed Abstract available

BANNIETTIS N, Wysocki J, Szenborn L, Phongsamart W, et al
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, c
Vaccine. 2022 Sep 20. pii: S0264-410X(22)01086.
PubMed Abstract available

GRAAF A, Petric PP, Sehl-Ewert J, Henritzi D, et al
Cold-passaged isolates and bat-swine influenza a chimeric viruses as modified live-attenuated vaccines against influenza a viruses in pigs.
Vaccine. 2022 Sep 19. pii: S0264-410X(22)01108.
PubMed Abstract available

SHI T, Meng L, Li D, Jin N, et al
Effect of different vaccine strategies for the control of Japanese encephalitis in mainland China from 1961 to 2020: A quantitative analysis.
Vaccine. 2022 Sep 19. pii: S0264-410X(22)01127.
PubMed Abstract available

NTZIORA F, Georgia Kostaki E, Karapanou A, Mylona M, et al
Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers.
Vaccine. 2022 Sep 19. pii: S0264-410X(22)01150.
PubMed Abstract available

HUANG ST, Huang YC, Kuo E, Yang YM, et al
Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001-2015).
Vaccine. 2022 Sep 17. pii: S0264-410X(22)01084.
PubMed Abstract available

LI L, Li Y, Bai Y, Li G, et al
Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase b randomized, double-blind, parallel-controlled study.
Vaccine. 2022 Sep 16. pii: S0264-410X(22)01114.
PubMed Abstract available

TILEY KS, White JM, Andrews N, Tessier E, et al
Equity of the Meningitis B vaccination programme in England, 2016-2018.
Vaccine. 2022 Sep 15. pii: S0264-410X(22)01111.
PubMed Abstract available

YU M, Chi X, Huang S, Wang Z, et al
A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26.
Vaccine. 2022 Sep 15. pii: S0264-410X(22)01103.
PubMed Abstract available

FRANKENTHAL D, Zatlawi M, Karni-Efrati Z, Keinan-Boker L, et al
COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01078.
PubMed Abstract available

CREVECOEUR J, Hens N, Neyens T, Lariviere Y, et al
Change in COVID19 outbreak pattern following vaccination in long-term care facilities in Flanders, Belgium.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01124.
PubMed Abstract available

CARRENO JM, Singh G, Tcheou J, Srivastava K, et al
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01003.
PubMed Abstract available

ACEIL J, Paschall AV, Knoot CJ, Robinson LS, et al
Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01112.
PubMed Abstract available

SUZUKI H, Noguchi T, Matsugu N, Suzuki A, et al
Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01104.
PubMed Abstract available

STANFIELD BA, Bravo FJ, Dixon DA, Chouljenko VN, et al
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01119.
PubMed Abstract available

DIEMERT DJ, Zumer M, Campbell D, Grahek S, et al
Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naive adults.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01113.
PubMed Abstract available

OSEI I, Sarwar G, Hossain I, Sonko K, et al
Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01125.
PubMed Abstract available

ZACE D, La Gatta E, Petrella L, Di Pietro ML, et al
The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01118.
PubMed Abstract available

MONFARED IG
The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01107.
PubMed Abstract available

FRIEDMAN-KLABANOFF DJ, Tjaden AH, Santacatterina M, Munawar I, et al
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01116.
PubMed Abstract available

YAMANAKA A, Rattanaamnuaychai P, Matsuda M, Suzuki R, et al
Engineered flavivirus vaccines control induction of crossreactive infection-enhancing and -neutralizing antibodies.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01110.
PubMed Abstract available

HAO F, Bai Y, Xie X, Yuan T, et al
Phenotypic characteristics and protective efficacy of an attenuated Mycoplasma hyopneumoniae vaccine by aerosol administration.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01080.
PubMed Abstract available

DAY ME, Klein M, Sucharew H, Carol Burkhardt M, et al
Declining influenza vaccination rates in an underserved pediatric primary care center during the COVID-19 pandemic.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01121.
PubMed Abstract available

NAEIM A, Guerin RJ, Baxter-King R, Okun AH, et al
Strategies to increase the intention to get vaccinated against COVID-19: Findings from a nationally representative survey of US adults, October 2020 to October 2021.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01117.
PubMed Abstract available

NOWALK MP, D'Agostino H, Dauer K, Stiegler M, et al
Corrigendum to "Estimating the burden of adult hospitalized RSV infection including special populations". [Vaccine 40(31) (2022) 4121-4127].
Vaccine. 2022 Sep 10. pii: S0264-410X(22)01123.
PubMed

NIEMINEN H, Lahdenkari M, Syrjanen RK, Nohynek H, et al
Lower incidence of hospital-treated infections in infants under 3 months of age vaccinated with BCG.
Vaccine. 2022 Sep 9. pii: S0264-410X(22)01087.
PubMed Abstract available

DEIFALLAH YOUSIF M, Felek A, Saydam M, Wilson S, et al
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS colonisation of vaginal epithelial cells.
Vaccine. 2022 Sep 9. pii: S0264-410X(22)01062.
PubMed Abstract available

ISHIGURO C, Mimura W, Murata F, Fukuda H, et al
Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine. 2022 Sep 9. pii: S0264-410X(22)01077.
PubMed Abstract available

VANDEBRIEL RJ, Stalpers CAL, Vermeulen JP, Remkes M, et al
Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation.
Vaccine. 2022;40:5601-5607.
PubMed Abstract available

MOORE KA, Osterholm MT, Lackritz EM, Poland GA, et al
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: Setting a path to address coronavirus threats.
Vaccine. 2022 Sep 8. pii: S0264-410X(22)01079.
PubMed

TEPEROWSKI MONRAD J, Quaade S, Powell-Jackson T
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates.
Vaccine. 2022 Sep 8. pii: S0264-410X(22)01041.
PubMed Abstract available

JOSE PRIYA TA, Kappalli S
Modern biotechnological strategies for vaccine development in aquaculture - Prospects and challenges.
Vaccine. 2022 Sep 7. pii: S0264-410X(22)01083.
PubMed Abstract available

CEANNT R, Vallieres F, Burns H, Murphy J, et al
Covid-19 vaccine hesitancy and resistance amongst parents of children under 18 years of age in Ireland.
Vaccine. 2022 Sep 7. pii: S0264-410X(22)01082.
PubMed Abstract available

MOK CC, Chan KL, Tse SM
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01067.
PubMed Abstract available

LUBIS TA, Gunardi H, Herqutanto, Soedjatmiko S, et al
Educational videos to address vaccine hesitancy in childhood immunization.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01035.
PubMed Abstract available

HABERSAAT KB, Narayan S, Malue Nielsen S, Scherzer M, et al
How health workers can make a difference in the public COVID-19 vaccination response.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01081.
PubMed

PERRIER Q, Lupo J, Gerster T, Augier C, et al
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01064.
PubMed Abstract available

NUORTI JP, Rinta-Kokko H, Toropainen M, Siira L, et al
Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Finland.
Vaccine. 2022 Sep 5. pii: S0264-410X(22)01037.
PubMed Abstract available

LUHATA LUNGAYO C, Burke RM, Cikomola A, Mukamba E, et al
Epidemiology and pre-vaccine burden of rotavirus diarrhea in Democratic Republic of Congo (DRC): Results of sentinel surveillance, 2009-2019.
Vaccine. 2022 Sep 3. pii: S0264-410X(22)01031.
PubMed Abstract available

ARORA AK, Chinsky K, Keller C, Mayers I, et al
A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial.
Vaccine. 2022 Sep 3. pii: S0264-410X(22)01042.
PubMed Abstract available

QI L, Sun Y, Juraska M, Moodie Z, et al
Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia.
Vaccine. 2022 Sep 3. pii: S0264-410X(22)01043.
PubMed Abstract available

SALUJA T, Rai GK, Chaudhary S, Kanodia P, et al
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.
Vaccine. 2022 Sep 2. pii: S0264-410X(22)01009.
PubMed Abstract available

MANOHAR MM, Campbell BE, Walduck AK, Moore RJ, et al
Enhancement of live vaccines by co-delivery of immune modulating proteins.
Vaccine. 2022 Sep 2. pii: S0264-410X(22)01049.
PubMed Abstract available

SAEZ-LLORENS X, Chan M, DeAntonio R, Petersen T, et al
Persistence of protective anti-poliovirus antibody levels in 4-year-old children previously primed with Picovax(R), a trivalent, aluminium-adjuvanted reduced dose inactivated polio vaccine.
Vaccine. 2022 Sep 2. pii: S0264-410X(22)00858.
PubMed Abstract available

LEWIN B, Qian L, Huang R, Sy LS, et al
Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink.
Vaccine. 2022 Sep 2. pii: S0264-410X(22)01002.
PubMed Abstract available

VESGA JF, Metras R, Clark MHA, Ayazi E, et al
Vaccine efficacy trials for Crimean-Congo haemorrhagic fever: Insights from modelling different epidemiological settings.
Vaccine. 2022 Sep 1. pii: S0264-410X(22)01051.
PubMed Abstract available

BOLSEWICZ KT, Steffens MS, Karpish L, Bullivant B, et al
"Every interaction you have ...should be an opportunity to discuss and offer influenza vaccination". Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families living in New South Wales, Australia.
Vaccine. 2022 Sep 1. pii: S0264-410X(22)01047.
PubMed Abstract available

August 2022

HRIN ML, Emmerich VK, Ip EH, Feldman SR, et al
Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States.
Vaccine. 2022 Aug 31. pii: S0264-410X(22)01052.
PubMed Abstract available

FRAIMAN J, Erviti J, Jones M, Greenland S, et al
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
Vaccine. 2022 Aug 30. pii: S0264-410X(22)01028.
PubMed Abstract available

JACOBSON M, Chang TY, Shah M, Pramanik R, et al
Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial.
Vaccine. 2022 Aug 30. pii: S0264-410X(22)01050.
PubMed Abstract available

SANCHEZ-SAEZ F, Peiro S, Cuenca L, Vanaclocha H, et al
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01007.
PubMed Abstract available

SARKAR P, Chandrasekaran V, Gunasekaran D, Chinnakali P, et al
COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: A cross sectional descriptive study.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01040.
PubMed Abstract available

CAO X, Zai J, Zhao Q, Xie L, et al
Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01044.
PubMed Abstract available

KAMAL HOSSAIN M, Hassanzadeganroudsari M, Feehan J, Deraos G, et al
Development and characterization of a novel conjugated methamphetamine vaccine.
Vaccine. 2022 Aug 27. pii: S0264-410X(22)01033.
PubMed Abstract available

DOYON-PLOURDE P, Fortin E, Quach C
Evaluation of the 2018-2019 vaccine effectiveness against medically attended influenza-like illness using medical records and claims data.
Vaccine. 2022 Aug 27. pii: S0264-410X(22)00976.
PubMed Abstract available

ROSHCHINA Y, Roshchin S, Rozhkova K
Determinants of COVID-19 vaccine hesitancy and resistance in Russia.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01032.
PubMed Abstract available

TERESA VIETRI M, D'Elia G, Caliendo G, Passariello L, et al
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01034.
PubMed Abstract available

PHAM D, Shukla A, Welch K, Villa A, et al
Assessing knowledge of human papillomavirus among men who have sex with men (MSM) using targeted dating applications.
Vaccine. 2022;40:5376-5383.
PubMed Abstract available

CHUAN VOO T, Savulescu J, Schaefer O, Ho Zhi Ling A, et al
COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications.
Vaccine. 2022;40:5333-5337.
PubMed Abstract available

HEMMI T, Ainai A, Hashiguchi T, Tobiume M, et al
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01038.
PubMed Abstract available

KIKUT A, Clark D, Jesch E, Hornik R, et al
Strengthened belief in vaccine effectiveness predicted increased COVID-19 vaccination intention and behaviour: Results from a nationally representative longitudinal survey of U.S. adults from July 2020 to April/May 2021.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01036.
PubMed Abstract available

OKUYAMA M, Morino S, Tanaka K, Nakamura-Miwa H, et al
Vasovagal reactions after COVID-19 vaccination in Japan.
Vaccine. 2022 Aug 25. pii: S0264-410X(22)01046.
PubMed Abstract available

CATHARINA DE BEER J, Goto D, Miller-Janson H, Holl R, et al
Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019.
Vaccine. 2022 Aug 24. pii: S0264-410X(22)00817.
PubMed Abstract available

CALO WA, Lennon RP, Ruffin Iv MT, Keller C, et al
Support for HPV vaccine school-entry requirements in the United States: The role of exemption policies.
Vaccine. 2022 Aug 24. pii: S0264-410X(22)00983.
PubMed Abstract available

LIM AH, Ab Rahman N, Ong SM, Paraja J, et al
Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study.
Vaccine. 2022 Aug 24. pii: S0264-410X(22)01005.
PubMed Abstract available

ESSON R, Rodrigues De Sousa E, Benair L, Devard N, et al
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate.
Vaccine. 2022 Aug 23. pii: S0264-410X(22)00939.
PubMed Abstract available

KURUKULASURIYA S, Ahmed KA, Ojkic D, Gunawardana T, et al
Evaluation of five circulating strains of variant infectious bursal disease virus (varIBDV) for their immunogenicity as broiler breeder vaccines and protective efficacy in neonatal broiler chicks.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01000.
PubMed Abstract available

ROMANO L, Tosti ME, Zanetti AR
Beyond 30 years of universal anti-hepatitis B vaccination in Italy: Success and areas of improvement.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)00966.
PubMed

PRUDDEN HJ, Achilles SL, Schocken C, Broutet N, et al
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)00999.
PubMed Abstract available

MACKLIN GR, Goel AK, Mach O, Tallis G, et al
Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)00962.
PubMed Abstract available

MARRON L, Ferenczi A, O'Brien KM, Cotter S, et al
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01013.
PubMed Abstract available

STIVANELLO E, Beghelli C, Cardoni F, Giansante C, et al
Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01029.
PubMed Abstract available

WANG X, Deng Y, Zhao L, Wang L, et al
Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01030.
PubMed Abstract available

KANOKUDOM S, Assawakosri S, Suntronwong N, Chansaenroj J, et al
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01011.
PubMed Abstract available

DOCHEZ C, Duclos P, MacDonald N, Steffen C, et al
Advanced vaccinology training globally: Update and impact of the COVID-19 crisis.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01006.
PubMed Abstract available

KURASHIMA K, Numano T, Yoshino A, Osawa A, et al
Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01027.
PubMed Abstract available

WILLIS GA, Bloomfield L, Berry M, Bulsara C, et al
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01026.
PubMed Abstract available

TOAPANTA-YANCHAPAXI L, Chiquete E, Avila-Rojo E, Lopez-Yanez S, et al
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01012.
PubMed Abstract available

CLEMENS SAC, Fortaleza CMCB, Crowe M, Pollard A, et al
Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01010.
PubMed Abstract available

JAFFRY M, Mostafa F, Mandava K, Rosario S, et al
No significant increase in Guillain-Barre syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01025.
PubMed Abstract available

PSARIDI L, Maltezou HC, Simonidou S, Lialliou I, et al
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection.
Vaccine. 2022 Aug 19. pii: S0264-410X(22)01008.
PubMed Abstract available

MOHAMED TJ, Fong SM, Nadarajaw T, Choo CM, et al
Burden of pertussis among young infants in Malaysia: A hospital-based surveillance study.
Vaccine. 2022;40:5241-5247.
PubMed Abstract available

DEJONG MA, Wolf MA, Bitzer GJ, Hall JM, et al
CpG 1018(R) adjuvant enhances Tdap immune responses against Bordetella pertussis in mice.
Vaccine. 2022;40:5229-5240.
PubMed Abstract available

STOECKEL F, Stockli S, Phillips J, Lyons B, et al
Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)00965.
PubMed Abstract available

LAFFAN MA, Rees S, Yadavalli M, Ferstenberg LB, et al
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)00964.
PubMed Abstract available

PRINGLE W, Greyson D, Graham JE, Dube E, et al
Suitable but requiring support: How the midwifery model of care offers opportunities to counsel the vaccine hesitant pregnant population.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)00953.
PubMed Abstract available

AMANI A, Ngo Bama S, Dia M, Nguefack Lekelem S, et al
Challenges, best practices, and lessons learned from oral cholera mass vaccination campaign in urban Cameroon during the COVID-19 era.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)01004.
PubMed Abstract available

ISHIDA M, Mulou N, Mahal A
Travel time to health facilities in Papua New Guinea: Implications for coverage and equity in child vaccinations.
Vaccine. 2022 Aug 17. pii: S0264-410X(22)00958.
PubMed Abstract available

LINNANDER E, Ineza L, Mupeta Bobo P, Bechtold K, et al
Improving management of vaccine supply chains: A multi-methods evaluation of vSTEP in Zambia.
Vaccine. 2022 Aug 17. pii: S0264-410X(22)00914.
PubMed Abstract available

WYMORE BRAND M, Anderson TK, Kitikoon P, Brian Kimble J, et al
Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease.
Vaccine. 2022 Aug 17. pii: S0264-410X(22)00937.
PubMed Abstract available

VISKUPIC F, Wiltse DL, Badahdah A
Reminders of existing vaccine mandates increase support for a COVID-19 vaccine mandate: Evidence from a survey experiment.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00978.
PubMed Abstract available

ELLIOTT CBP, Chambers CS
A historical analysis of vaccine mandates in the United States military and its application to the COVID-19 vaccine mandate.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00982.
PubMed Abstract available

ALKETBI LMB, Al Hosani F, Al Memari S, Al Mazrouei S, et al
Parents' views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00954.
PubMed Abstract available

MATSUURA T, Fukushima W, Nakagama Y, Kido Y, et al
Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00984.
PubMed Abstract available

CASEROTTI M, Gavaruzzi T, Girardi P, Sellaro R, et al
People's perspectives about COVID-19 vaccination certificate: Findings from a representative Italian sample.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00980.
PubMed Abstract available

SCHMIDTKE KA, Skrybant M, Kudrna L, Russell S, et al
A workshop to co-design messages that may increase uptake of vaccines: A case study.
Vaccine. 2022 Aug 12. pii: S0264-410X(22)00951.
PubMed Abstract available

XIROGIANNI A, Marmaras N, Georgakopoulou T, Papandreou A, et al
Pneumococcal meningitis in Greece: A retrospective serotype surveillance study in the post-PCV13 era (2010-2020).
Vaccine. 2022;40:5079-5087.
PubMed Abstract available

OMER SB, O'Leary ST, Bednarczyk RA, Ellingson MK, et al
Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial.
Vaccine. 2022;40:4955-4963.
PubMed Abstract available

HALASA N, Williams J, Faouri S, Shehabi A, et al
Corrigendum to "Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan" [Vaccine 33(47) (2015) 6479-6487].
Vaccine. 2022 Aug 11. pii: S0264-410X(22)00959.
PubMed

HOSHI SL, Okubo R, Tabuchi K, Seposo X, et al
Cost-effectiveness analyses of monovalent mumps vaccination programs for Japanese children.
Vaccine. 2022 Aug 11. pii: S0264-410X(22)00960.
PubMed Abstract available

MARKOWITZ LE, Drolet M, Lewis RM, Lemieux-Mellouki P, et al
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs.
Vaccine. 2022 Aug 11. pii: S0264-410X(22)00834.
PubMed Abstract available

MAEDA H, Gopal Dhoubhadel B, Sando E, Suzuki M, et al
Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020.
Vaccine. 2022 Aug 10. pii: S0264-410X(22)00938.
PubMed Abstract available

GUSMAO MR, Ostolin TLVDP, Carvalho LM, Costa AFP, et al
Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis.
Vaccine. 2022 Aug 10. pii: S0264-410X(22)00961.
PubMed Abstract available

YELVERTON V, Hair NL, Ghosh SH, Mfinanga SG, et al
Beyond coverage: Rural-urban disparities in the timeliness of childhood vaccinations in Tanzania.
Vaccine. 2022 Aug 9. pii: S0264-410X(22)00907.
PubMed Abstract available

PROUT A, Rustandi RR, Tubbs C, Winters MA, et al
Functional profiling of Covid 19 vaccine candidate by flow virometry.
Vaccine. 2022 Aug 9. pii: S0264-410X(22)00963.
PubMed Abstract available

PERROUD JM, Soldano S, Avancena ALV, Wagner A, et al
Adult vaccination uptake strategies in low- and middle-income countries: A systematic review.
Vaccine. 2022 Aug 8. pii: S0264-410X(22)00952.
PubMed Abstract available

HU S, Xiong C, Li Q, Wang Z, et al
COVID-19 vaccine hesitancy cannot fully explain disparities in vaccination coverage across the contiguous United States.
Vaccine. 2022 Aug 8. pii: S0264-410X(22)00947.
PubMed Abstract available

THOBANI RS, Yousafzai MT, Sultana S, Kazi AM, et al
Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan.
Vaccine. 2022 Aug 6. pii: S0264-410X(22)00840.
PubMed Abstract available

ESTRELA M, Magalhaes Silva T, Roque V, Rebelo Gomes E, et al
Unravelling the drivers behind COVID-19 vaccination hesitancy and refusal among teachers: A nationwide study.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00955.
PubMed Abstract available

BURGER E, Baussano I, Kim JJ, Laprise JF, et al
Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00910.
PubMed

GAGNEUX-BRUNON A, Guyot E, Detoc M, Botelho-Nevers E, et al
Midwives' attitudes toward participation of pregnant individuals in a preventive vaccine hypothetical clinical trial.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00945.
PubMed Abstract available

DE SWART RL, de Leeuw OS, Oreshkova N, Gerhards NM, et al
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.
Vaccine. 2022;40:4676-4681.
PubMed Abstract available

HAO L, Kuttel MM, Ravenscroft N, Thompson A, et al
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A.
Vaccine. 2022;40:4872-4880.
PubMed Abstract available

LI YA, Sun Y, Zhang Y, Wang S, et al
Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a virus-like particles induces a protective immune response against porcine circovirus type 2 in mice.
Vaccine. 2022;40:4732-4741.
PubMed Abstract available

YEO J, Furr Gudmundsen C, Fazel S, Corrigan A, et al
A behavior change model to address caregiver hesitancy around COVID-19 vaccination in pediatrics.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00949.
PubMed Abstract available

ULRICH AK, Pankratz GK, Bohn B, Yendell S, et al
COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00956.
PubMed Abstract available

TOIZUMI M, Satoh C, Quilty BJ, Nguyen HAT, et al
Effect of pneumococcal conjugate vaccine on prevalence of otitis media with effusion among children in Vietnam.
Vaccine. 2022 Aug 4. pii: S0264-410X(22)00944.
PubMed Abstract available

SQUIRE JD, Joshi AY
Response to mRNA COVID-19 vaccination in three XLA patients.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00941.
PubMed Abstract available

LOURENCO GUIMARAES E, Chissaque A, Pecenka C, Clark A, et al
Cost-effectiveness of rotavirus vaccination in Mozambique.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00940.
PubMed Abstract available

QUIAMBAO BP, Lim JG, Bosch Castells V, Augard C, et al
One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess im
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00923.
PubMed Abstract available

SINGH H, Chase AJ
Measuring vaccine acceptance and knowledge within health professions education.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00926.
PubMed Abstract available

SNYDER J, Goldenberg M, Crooks VA, Katz R, et al
Crowdfunding narratives and the valuation of vaccines for COVID-19.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00946.
PubMed Abstract available

CIMA MJ, McCormick D, Porter A 3rd, Zohoori N, et al
COVID-19 vaccine uptake among Arkansas public K-12 school teachers and staff.
Vaccine. 2022 Aug 2. pii: S0264-410X(22)00942.
PubMed Abstract available

DE MUNTER AC, Hautvast JLA, Ruijs WLM, Henri Spaan D, et al
Deciding about maternal pertussis vaccination: associations between intention, and needs and values in a vaccine-hesitant religious group.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00924.
PubMed

NARSINGAM S, Munson J, Drescher F
Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00922.
PubMed Abstract available

BAUMER-MOURADIAN SH, Hart RJ, Bone JN, Seiler M, et al
Should COVID-19 vaccines be mandated in schools? - an international caregiver perspective.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00921.
PubMed Abstract available

KORODI M, Horvath I, Rakosi K, Jenei Z, et al
Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00936.
PubMed Abstract available

July 2022

SHINKAI M, Sonoyama T, Kamitani A, Shibata RY, et al
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study.
Vaccine. 2022;40:4328-4333.
PubMed Abstract available

DE BROUWER L, David D, Espitia Ballestas M, Sloots A, et al
Prevalidation of the cAMP-PTx reporter assay for quantitative assessment of pertussis toxin activity.
Vaccine. 2022;40:4513-4521.
PubMed Abstract available

COWLING BJ, Wong IOL, Shiu EYC, Lai AYT, et al
Strength and durability of antibody responses to BNT162b2 and CoronaVac.
Vaccine. 2022;40:4312-4317.
PubMed Abstract available

SADOFF J, Le Gars M, Brandenburg B, Cardenas V, et al
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials.
Vaccine. 2022;40:4403-4411.
PubMed Abstract available

LIU Z, Hosomi K, Kunisawa J
Utilization of gut environment-mediated control system of host immunity in the development of vaccine adjuvants.
Vaccine. 2022 Jul 30. pii: S0264-410X(22)00918.
PubMed Abstract available

NOWALK MP, D'Agostino H, Dauer K, Stiegler M, et al
Estimating the burden of adult hospitalized RSV infection including special populations.
Vaccine. 2022;40:4121-4127.
PubMed Abstract available

BOTTCHER J, Bauer BU, Ambros C, Alex M, et al
Long-term control of Coxiellosis in sheep by annual primary vaccination of gimmers.
Vaccine. 2022 Jul 29. pii: S0264-410X(22)00917.
PubMed Abstract available

CHEN H, Huang Z, Chang S, Hu M, et al
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiorit
Vaccine. 2022 Jul 29. pii: S0264-410X(22)00919.
PubMed Abstract available

ROSE O, Erzkamp S, Schobel W, Grajeda M, et al
COVID-19 vaccinations in German pharmacies: A survey on patient and provider satisfaction.
Vaccine. 2022 Jul 28. pii: S0264-410X(22)00925.
PubMed Abstract available

MARIN-LOPEZ A, Wang Y, Jiang J, Ledizet M, et al
Erratum to "AgBR1 and NeSt1 antisera protect mice from Aedes aegypti-borne Zika infection" [Vaccine 39(12) (2021) 1675-1679].
Vaccine. 2022 Jul 27. pii: S0264-410X(22)00608.
PubMed

BYRNE C, Coombs D, Gantt S
Modestly protective cytomegalovirus vaccination of young children effectively prevents congenital infection at the population level.
Vaccine. 2022 Jul 27. pii: S0264-410X(22)00913.
PubMed Abstract available

RAMMAURO F, Carrion F, Olivero-Deibe N, Flo M, et al
Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2.
Vaccine. 2022 Jul 27. pii: S0264-410X(22)00911.
PubMed Abstract available

QUIAMBAO B, Montalban C, Minutello AM, Guinet-Morlot F, et al
Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phaseII pre-exposure prophylaxis regimen study.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00830.
PubMed Abstract available

KRAUSE PR, Arora N, Dowling W, Munoz-Fontela C, et al
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00916.
PubMed

SHENYU W, Xiaoqian D, Bo C, Xuan D, et al
Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00908.
PubMed Abstract available

O'KENNEDY MM, Coetzee P, Koekemoer O, du Plessis L, et al
Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR(-/-) mice.
Vaccine. 2022 Jul 25. pii: S0264-410X(22)00848.
PubMed Abstract available

SPENCER CLINTON JL, Hoornweg TE, Tan J, Peng R, et al
EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice.
Vaccine. 2022 Jul 22. pii: S0264-410X(22)00891.
PubMed Abstract available

CHANG MJ, Ollivault-Shiflett M, Schuman R, Ngoc Nguyen S, et al
Genetically detoxified tetanus toxin as a vaccine and conjugate carrier protein.
Vaccine. 2022 Jul 21. pii: S0264-410X(22)00886.
PubMed Abstract available

SIMSEK C, Bloemen M, Jansen D, Descheemaeker P, et al
Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis.
Vaccine. 2022 Jul 21. pii: S0264-410X(22)00853.
PubMed Abstract available

PAWASKAR M, Gil-Rojas Y, Irene Parellada C, Rey-Velasco A, et al
The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008-2019.
Vaccine. 2022 Jul 21. pii: S0264-410X(22)00889.
PubMed Abstract available

MCADAMS D, Estrada M, Holland D, Singh J, et al
Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency.
Vaccine. 2022 Jul 21. pii: S0264-410X(22)00892.
PubMed Abstract available

LORENZETTI L, Haydarov R, Namey E, Lawton A, et al
Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria.
Vaccine. 2022 Jul 20. pii: S0264-410X(22)00591.
PubMed Abstract available

DUGORD C, Franc C
Trajectories and individual determinants of repeated seasonal flu vaccination use over the long term using data from the French E3N cohort.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00855.
PubMed Abstract available

MCMILLAN CLD, Amarilla AA, Modhiran N, Choo JJY, et al
Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00888.
PubMed Abstract available

SETHY G, Chisema M, Sharma L, Joshi K, et al
COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00887.
PubMed Abstract available

MIMURA W, Ishiguro C, Fukuda H
Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged>/=75years in Japan: The LIFE-VENUS Study.
Vaccine. 2022 Jul 15. pii: S0264-410X(22)00852.
PubMed Abstract available

WALTON S, Cortina-Borja M, Dezateux C, Griffiths LJ, et al
Linking cohort data and Welsh routine health records to investigate children at risk of delayed primary vaccination.
Vaccine. 2022 Jul 13. pii: S0264-410X(22)00849.
PubMed Abstract available

IMANISHI Y, Kinoshita T, Sakamoto M, Ichimiya M, et al
Importance of human papillomavirus vaccination leaflets focusing on the safety profile targeted pediatricians in Japan.
Vaccine. 2022 Jul 13. pii: S0264-410X(22)00861.
PubMed Abstract available

VASUDEVAN L, Bruening R, Hung A, Woolson S, et al
COVID-19 vaccination intention and activation among health care system employees: A mixed methods study.
Vaccine. 2022 Jul 13. pii: S0264-410X(22)00884.
PubMed Abstract available

ORTQVIST AK, Dahlqwist E, Magnus MC, Ljung R, et al
COVID-19 vaccination in pregnant women in Sweden and Norway.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00859.
PubMed Abstract available

PRIDDY FH, Williams M, Carson S, Lavender B, et al
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00885.
PubMed Abstract available

GODDARD K, Lewis N, Fireman B, Weintraub E, et al
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00860.
PubMed Abstract available

CUFFEL A, Maylin S, Le Buanec H, Delaugerre C, et al
Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients.
Vaccine. 2022 Jul 11. pii: S0264-410X(22)00857.
PubMed Abstract available

PADRON-REGALADO E, Medina-Rivero E
Perspectives for licensing vaccines in Mexico.
Vaccine. 2022 Jul 11. pii: S0264-410X(22)00854.
PubMed Abstract available

HATFALUDI T, Rezaee MS, Liebhart D, Bilic I, et al
Experimental reproduction of histomonosis caused by Histomonas meleagridis genotype 2 in turkeys can be prevented by oral vaccination of day-old birds with a monoxenic genotype 1 vaccine candidate.
Vaccine. 2022 Jul 11. pii: S0264-410X(22)00851.
PubMed Abstract available

COURCIER EA, Collins SF, McCormick CM, Arnold ME, et al
The impact of BCG strains and repeat vaccinations on immunodiagnostic tests in Eurasian badgers (Meles meles).
Vaccine. 2022 Jul 9. pii: S0264-410X(22)00850.
PubMed Abstract available

WYPLOSZ B, Fernandes J, Sultan A, Roche N, et al
Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00841.
PubMed Abstract available

MISCHLINGER J, Jaeger VK, Ciurea A, Gabay C, et al
Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00760.
PubMed Abstract available

ZHANG Y, Wang Y, Jia C, Li G, et al
Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects >/=3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00846.
PubMed Abstract available

BADRAN G, Angrand L, Masson JD, Crepeaux G, et al
Physico-chemical properties of aluminum adjuvants in vaccines: Implications for toxicological evaluation.
Vaccine. 2022 Jul 6. pii: S0264-410X(22)00833.
PubMed Abstract available

REINHARDT A, Rossmann C, Engel E
Radio public service announcements to promote vaccinations for older adults: Effects of framing and distraction.
Vaccine. 2022 Jul 6. pii: S0264-410X(22)00805.
PubMed Abstract available

CHADWICK C, Friede M, Moen A, Nannei C, et al
Technology transfer programme for influenza vaccines - Lessons from the past to inform the future.
Vaccine. 2022 Jul 6. pii: S0264-410X(22)00826.
PubMed

OSTROPOLETS A, Shoener Dunham L, Johnson KD, Liu J, et al
Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.
Vaccine. 2022 Jul 5. pii: S0264-410X(22)00837.
PubMed Abstract available

XIRIDOU M, Adam P, Meiberg A, Visser M, et al
The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study.
Vaccine. 2022 Jul 4. pii: S0264-410X(22)00847.
PubMed Abstract available

MCCORMICK DW, Konkle SL, Magleby R, Chakrabarti AK, et al
SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
Vaccine. 2022 Jul 4. pii: S0264-410X(22)00835.
PubMed Abstract available

CASTILLO-CANO B, Martin-Perez M, Llorente-Garcia A, Montero-Corominas D, et al
Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9-18 years: A time-varying cohort study.
Vaccine. 2022 Jul 2. pii: S0264-410X(22)00829.
PubMed Abstract available

BARNARD JG, Marsh R, Anderson-Mellies A, Williams JL, et al
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics.
Vaccine. 2022 Jul 2. pii: S0264-410X(22)00844.
PubMed Abstract available

HOU Z, Guo J, Lai X, Zhang H, et al
Influenza vaccination hesitancy and its determinants among elderly in China: A national cross-sectional study.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00832.
PubMed Abstract available

SKIRROW H, Barnett S, Bell S, Mounier-Jack S, et al
Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00845.
PubMed Abstract available

BARRALL AL, Hoff NA, Nkamba DM, Musene K, et al
Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00842.
PubMed Abstract available

June 2022

NASREEN S, Gebretekle GB, Lynch M, Kurdina A, et al
Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: A scoping review.
Vaccine. 2022 Jun 30. pii: S0264-410X(22)00825.
PubMed Abstract available

HILLS T, Paterson A, Woodward R, Middleton F, et al
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine.
Vaccine. 2022 Jun 29. pii: S0264-410X(22)00839.
PubMed Abstract available

PICHON S, Moureau A, Petit C, Chu L, et al
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study.
Vaccine. 2022 Jun 28. pii: S0264-410X(22)00806.
PubMed Abstract available

BETTENCOURT C, Nogueira P, Paulo Gomes J, Joao Simoes M, et al
Vaccines against Neisseria meningitidis serogroup B strains - What does genomics reveal on the Portuguese strain's coverage.
Vaccine. 2022 Jun 28. pii: S0264-410X(22)00807.
PubMed Abstract available

MEDEIROS MZ, Soares PF, Fialho BC, Gauss L, et al
Vaccine innovation model: A technology transfer perspective in pandemic contexts.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00823.
PubMed Abstract available

WONG SC, Chan VW, Lam GKM, Yuen LL, et al
The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00836.
PubMed Abstract available

LEE JT, Sean Hu S, Zhou T, Bonner KE, et al
Employer requirements and COVID-19 vaccination and attitudes among healthcare personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August - September 2021.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00838.
PubMed Abstract available

UFFMAN EA, Li SH, Chen JL, Allen N, et al
Kinetics of pneumococcal antibodies among HIV-exposed, uninfected infants in Botswana.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00828.
PubMed Abstract available

MOGHNIEH R, Abdallah D, Sayegh MH, Rahman Bizri A, et al
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3987-3988.
PubMed

CIMOLAI N
Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3985-3986.
PubMed

HU G, Jin WP, Yang ZH, Lv SY, et al
Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00768.
PubMed Abstract available

STRAUS W, Rubin H
COVID-19 vaccine safety monitoring in low and middle income countries - Time for a bold new approach.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00822.
PubMed

SHIVJI R, Conocchia R, Korakianiti E, Jekerle V, et al
Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA).
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00827.
PubMed Abstract available

SEYRAN M
Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00821.
PubMed Abstract available

AL-MUSTAPHA AI, Okechukwu O, Olayinka A, Muhammed OR, et al
A national survey of COVID-19 vaccine acceptance in Nigeria.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00818.
PubMed Abstract available

LOHMANN S, Albarracin D
Trust in the public health system as a source of information on vaccination matters most when environments are supportive.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00759.
PubMed Abstract available

HUANG L, Wasserman M, Grant L, Farkouh R, et al
Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00773.
PubMed Abstract available

ZHAO Z, Liao Y, Li Y, Jiang G, et al
Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00776.
PubMed Abstract available

CARTANYA-HUESO A, Martinez-Sanchez JM, Carlos Martin-Sanchez J, Lidon-Moyano C, et al
Relationship between double COVID-19 vaccine uptake and trust in effectiveness and safety of vaccination in general in 23 Member states of the European Union: an ecological study.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00820.
PubMed Abstract available

MAERTENS K, Leuridan E, Munoz FM, Zimmermann P, et al
Impact of vaccination during pregnancy on infants' immune responses to vaccinations- definitions and statistical approaches.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00811.
PubMed

BRAZ HMB, Silva MF, Carvalho TP, Silva LAD, et al
Pathogenesis of Brucella ovis in pregnant mice and protection induced by the candidate vaccine strain B. Ovis DeltaabcBA.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00812.
PubMed Abstract available

RONZANI P, Panizza F, Martini C, Savadori L, et al
Countering vaccine hesitancy through medical expert endorsement.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00780.
PubMed Abstract available

SOARES GH, Sethi S, Hedges J, Jamieson L, et al
Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00777.
PubMed Abstract available

WANG L, Zhang J, Meng S, Ge L, et al
Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00784.
PubMed Abstract available

HONDA-OKUBO Y, Cartee RT, Thanawastien A, Seung Yang J, et al
A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00809.
PubMed Abstract available

KORVES C, Izurieta HS, Smith J, Zwain GM, et al
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00816.
PubMed Abstract available

ULANOVA M, Huska B, Dubois S, McCready W, et al
Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00810.
PubMed Abstract available

DIONATO FAV, Jalalizadeh M, Buosi K, Visacri MB, et al
BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00803.
PubMed Abstract available

KASAIJA PD, Contreras M, Kabi F, Mugerwa S, et al
Oral vaccine formulation combining tick Subolesin with heat inactivated mycobacteria provides control of cross-species cattle tick infestations.
Vaccine. 2022 Jun 18. pii: S0264-410X(22)00804.
PubMed Abstract available

CASAGRANDE TZ, Costa-Rocha IAD, Gavi MBRO, Miyamoto ST, et al
Previous biological therapy and impairment of the IFN-gamma/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.
Vaccine. 2022 Jun 18. pii: S0264-410X(22)00703.
PubMed Abstract available

ATWELL JE, Lutz CS, Sparrow EG, Feikin DR, et al
Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
Vaccine. 2022 Jun 17. pii: S0264-410X(22)00783.
PubMed Abstract available

UWAMINO Y, Kurafuji T, Takato K, Sakai A, et al
Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00763.
PubMed Abstract available

CANADAY LM, Resnick JD, Liu H, Powell H, et al
HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00733.
PubMed Abstract available

TAY S, Bowen AC, Blyth CC, Clifford P, et al
A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00769.
PubMed Abstract available

MOUTA NUNES DE OLIVEIRA P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, Crespo Cordeiro C, et al
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00761.
PubMed Abstract available

GAMBRELL A, Sundaram M, Bednarczyk RA
Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00782.
PubMed Abstract available

TSENG HF, Sy LS, Ackerson BK, Lee GS, et al
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00756.
PubMed Abstract available

BRAUNFELD JB, Carson HN, Williams SR, Schwartz LM, et al
Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trials.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00778.
PubMed Abstract available

ARAUJO BC, Simakawa R, Munhoz LG, Carmo FB, et al
Rubella antibodies in vertically and horizontally HIV-infected young adults vaccinated early in life and response to a booster dose in those with seronegative results.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00774.
PubMed Abstract available

FOLEGATTI PM, Jenkin D, Morris S, Gilbert S, et al
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00755.
PubMed Abstract available

HERNANDEZ LM, Sumathy K, Sahastrabuddhe S, Excler JL, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00753.
PubMed Abstract available

CHUNG JR, Kim SS, Flannery B, Smith ME, et al
Vaccine-associated attenuation of subjective severity among outpatients with influenza.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00767.
PubMed Abstract available

RAZZAGHI H, Yankey D, Vashist K, Lu PJ, et al
COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00779.
PubMed Abstract available

PHATARPHEKAR A, Vidyadhar Reddy GEC, Gokhale A, Karanam G, et al
RelCoVax(R), a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00775.
PubMed Abstract available

SHOOTS-REINHARD B, Lawrence ER, Schulkin J, Peters E, et al
Excluding numeric side-effect information produces lower vaccine intentions.
Vaccine. 2022 Jun 10. pii: S0264-410X(22)00747.
PubMed Abstract available

ROLLIER CS, Dold C, Blackwell L, Linder A, et al
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Vaccine. 2022 Jun 10. pii: S0264-410X(22)00539.
PubMed Abstract available

HEININGER U
Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection - a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23):3120-3130.
Vaccine. 2022;40:3530.
PubMed

WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
In response to: JVAC-D-21-02863, detection of a potential error in the results of the manuscript, dementia risk following influenza vaccination in a large veteran cohort, that could call into question the main conclusion.
Vaccine. 2022;40:3529.
PubMed

VUICHARD-GYSIN D, Schoenenberger A
Detection of a potential error in the results of the manuscript "Dementia risk following influenza vaccination in a large veteran cohort" that could eventually call into question the main conclusion.
Vaccine. 2022;40:3528.
PubMed

SCHENK J, Abrams S, Litzroth A, Cornelissen L, et al
Identifying immunity gaps for measles using Belgian serial serology data.
Vaccine. 2022;40:3676-3683.
PubMed Abstract available

POLLET J, Strych U, Chen WH, Versteeg L, et al
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.
Vaccine. 2022;40:3655-3663.
PubMed Abstract available

SPARROW E, Adetifa I, Chaiyakunapruk N, Cherian T, et al
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Vaccine. 2022;40:3506-3510.
PubMed Abstract available

EVANS B, Jombart T
Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic.
Vaccine. 2022;40:3531-3535.
PubMed Abstract available

ZHAO FJ, Liu LT, Wang Z, Wang NX, et al
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00721.
PubMed Abstract available

HALME J, Syrjanen RK, Baum U, Palmu AA, et al
Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00716.
PubMed Abstract available

KUNASEKARAN MP, Chughtai AA, Heslop DJ, Poulos CJ, et al
Influenza cases in nine aged care facilities in Sydney, Australia over a three-year surveillance period, 2018-2020.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00476.
PubMed Abstract available

LEAV B, Straus W, White P, Leav A, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00752.
PubMed Abstract available

DIAZ-MENENDEZ M, de la Calle-Prieto F, Montejano R, Arsuaga M, et al
Clinical characteristics and outcome of hospitalized elderly patients with COVID- 19 after vaccine failure.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00751.
PubMed Abstract available

LIGHTOWLER MS, Manangazira P, Nackers F, Van Herp M, et al
Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00552.
PubMed Abstract available

CHICHILI GR, Smulders R, Santos V, Cywin B, et al
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00715.
PubMed Abstract available

OKUNO H, Satoh H, Morino S, Arai S, et al
Characteristics and incidence of vaccine adverse events after Bacille Calmette-Guerin vaccination: A national surveillance study in Japan from 2013 to 2017.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00672.
PubMed Abstract available

LIN K, Liu M, Bao L, Lv Q, et al
Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00765.
PubMed Abstract available

ZHANG H, Li Y, Peng S, Jiang Y, et al
The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00762.
PubMed Abstract available

KOBAYASHI T, Nishina Y, Tomoi H, Harada K, et al
Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00754.
PubMed Abstract available

BASS JR, Poland GA
Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00750.
PubMed Abstract available

NIESSEN FA, Knol MJ, Hahne SJM, Bonten MJM, et al
Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00758.
PubMed Abstract available

SMITH WJ, Ahl PL, Wang B, Hamm M, et al
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00673.
PubMed Abstract available

SLOTTE P, Karlsson LC, Soveri A
Attitudes towards mandatory vaccination and sanctions for vaccination refusal.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00697.
PubMed Abstract available

WALKER JL, Schultze A, Tazare J, Tamborska A, et al
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00757.
PubMed Abstract available

WYNBERG E, Han AX, Boyd A, van Willigen HDG, et al
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00748.
PubMed Abstract available

DAYTON L, Miller J, Strickland J, Davey-Rothwell M, et al
A socio-ecological perspective on parents' intentions to vaccinate their children against COVID-19.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00736.
PubMed Abstract available

EL-SHESHENY R, El Taweel A, Gomaa MR, Roshdy WH, et al
Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00734.
PubMed Abstract available

SHANMUGARAJ B, Khorattanakulchai N, Panapitakkul C, Malla A, et al
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00735.
PubMed Abstract available

HASHIMOTO M, Nagata N, Homma T, Maeda H, et al
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00718.
PubMed Abstract available

EUGENIA-TOLEDO-ROMANI M, Verdecia-Sanchez L, Rodriguez-Gonzalez M, Rodriguez-Noda L, et al
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00717.
PubMed Abstract available

FLYNN JA, Weber T, Cejas PJ, Cox KS, et al
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00382.
PubMed Abstract available

SLARVE M, Holznecht N, Reza H, Gilkes A, et al
Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00674.
PubMed Abstract available

WATANABE A, Nishida S, Burcu T, Shibahara T, et al
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-beta-cyclodextrin: A phase 1 clinical trial.
Vaccine. 2022 Jun 4. pii: S0264-410X(22)00677.
PubMed Abstract available

AB RAHMAN N, Lim MT, Lee FY, Lee SC, et al
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00700.
PubMed Abstract available

JANSSEN DF
A familiar species of Crank: Anti-Vaccinationists in medical history.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00665.
PubMed Abstract available

BILGIN GM, Lokuge K, Glass K
Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00684.
PubMed Abstract available

STEAD M, Ford A, Eadie D, Biggs H, et al
A "step too far" or "perfect sense"? A qualitative study of British adults' views on mandating COVID-19 vaccination and vaccine passports.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00696.
PubMed Abstract available

May 2022

AHMED S, Iqbal J, Sadiq K, Umrani F, et al
Association of Anti-Rotavirus IgA Seroconversion with Growth, Environmental Enteric Dysfunction and Enteropathogens in Rural Pakistani Infants.
Vaccine. 2022;40:3444-3451.
PubMed Abstract available

PILLSBURY M, Carias C, Samant S, Greenberg D, et al
Comparison of performance of varicella vaccines via infectious disease modeling.
Vaccine. 2022 May 31. pii: S0264-410X(22)00574.
PubMed Abstract available

HISYAM BIN ISMAIL CMK, Raihan Mohammad Shabani N, Chuah C, Hassan Z, et al
Shigella iron-binding proteins: An insight into molecular physiology, pathogenesis, and potential target vaccine development.
Vaccine. 2022 May 31. pii: S0264-410X(22)00679.
PubMed Abstract available

TOOR J, Li X, Jit M, Trotter CL, et al
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.
Vaccine. 2022 May 30. pii: S0264-410X(22)00698.
PubMed Abstract available

WOO EJ, Dimova RB
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system.
Vaccine. 2022 May 30. pii: S0264-410X(22)00704.
PubMed Abstract available

MERRICK E, Weissman JP, Patel SJ
Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies.
Vaccine. 2022 May 30. pii: S0264-410X(22)00699.
PubMed Abstract available

FISHMAN J, Salmon MK, Scheitrum D, Aleks Schaefer K, et al
Comparative effectiveness of mandates and financial policies targeting COVID-19 vaccine hesitancy: A randomized, controlled survey experiment.
Vaccine. 2022 May 30. pii: S0264-410X(22)00702.
PubMed Abstract available

HEMMING-HARLO M, Gylling A, Herse F, Haavisto I, et al
Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
Vaccine. 2022 May 28. pii: S0264-410X(22)00584.
PubMed Abstract available

KLEINWAKS G, Schmit V, Morrison J
Corrigendum to "Considering human challenge trials for tuberculosis vaccine development" [Vaccine 40(2) (2022) 173-174].
Vaccine. 2022 May 28. pii: S0264-410X(22)00675.
PubMed

SHAPIRO BEN DAVID S, Mizrahi B, Rahamim-Cohen D, Supino-Rosin L, et al
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study.
Vaccine. 2022 May 28. pii: S0264-410X(22)00668.
PubMed Abstract available

SHIOHARA M, Suzuki S, Shichinohe S, Ishigaki H, et al
Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
Vaccine. 2022 May 28. pii: S0264-410X(22)00640.
PubMed Abstract available

RODES-SANCHEZ M, Spencer J, Tantri A, Mitrovich R, et al
Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking.
Vaccine. 2022 May 27. pii: S0264-410X(22)00671.
PubMed

MACDONALD NE, Dube E, Comeau JL
Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework.
Vaccine. 2022 May 27. pii: S0264-410X(22)00669.
PubMed

SAVULESCU C, Krizova P, Valentiner-Branth P, Ladhani S, et al
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00581.
PubMed Abstract available

LAI X, Li M, Hou Z, Guo J, et al
Factors associated with caregivers' hesitancy to vaccinate children against influenza: A cross-sectional survey in China.
Vaccine. 2022 May 27. pii: S0264-410X(22)00606.
PubMed Abstract available

PATEL KM, Shafiq M, Malik AA, Cobanoglu A, et al
Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00680.
PubMed Abstract available

SOEGIARTO G, Wulandari L, Purnomosari D, Dhia Fahmita K, et al
Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2.
Vaccine. 2022 May 27. pii: S0264-410X(22)00676.
PubMed Abstract available

DUBE C, Paris-Robidas S, Andreani G, Gutzeit C, et al
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines.
Vaccine. 2022 May 27. pii: S0264-410X(22)00641.
PubMed Abstract available

MOSS P, Berenbaum F, Curigliano G, Grupper A, et al
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.
Vaccine. 2022 May 27. pii: S0264-410X(22)00682.
PubMed Abstract available

HALSTEAD IN, McKay RT, Lewis GJ
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort.
Vaccine. 2022 May 27. pii: S0264-410X(22)00678.
PubMed Abstract available

MOUSSAOUI S, Combes S, Ibanez G, Gautier A, et al
Are immigrants living in France more reluctant to receive vaccines than native-born French citizens? findings from the national health Barometer study.
Vaccine. 2022 May 26. pii: S0264-410X(22)00636.
PubMed Abstract available

ILESANMI MM, Adeyinka DA, Olakunde BO
Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses.
Vaccine. 2022 May 26. pii: S0264-410X(22)00632.
PubMed Abstract available

LARSEN L, Bistrup C, Sorensen SS, Boesby L, et al
Immunogenicity and safety of double dosage of pneumococcal vaccines in adult kidney transplant recipients and waiting list patients: A non-blinded, randomized clinical trial.
Vaccine. 2022 May 26. pii: S0264-410X(22)00635.
PubMed Abstract available

TAFURI S, Bianchi FP, Stefanizzi P
The public health and the question of the "best vaccine".
Vaccine. 2022 May 26. pii: S0264-410X(22)00639.
PubMed

HOFFMAN BL, Batra Hershey T, Chu KH, Sidani JE, et al
Moving vaccination beyond partisan politics.
Vaccine. 2022 May 26. pii: S0264-410X(22)00664.
PubMed

ZHOU Y, Hu X, Chen R, Wu J, et al
Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines.
Vaccine. 2022 May 26. pii: S0264-410X(22)00620.
PubMed Abstract available

JANKO MM, Joffe J, Michael D, Earl L, et al
Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis.
Vaccine. 2022 May 25. pii: S0264-410X(22)00637.
PubMed Abstract available

DUBE E, Gagnon D, MacDonald N
Between persuasion and compulsion: The case of COVID-19 vaccination in Canada.
Vaccine. 2022 May 25. pii: S0264-410X(22)00670.
PubMed

GAGHAN C, Adams D, Mohammed J, Crespo R, et al
Characterization of vaccine-induced immune responses against coccidiosis in broiler chickens.
Vaccine. 2022 May 25. pii: S0264-410X(22)00638.
PubMed Abstract available

ABRAHAM N, Spruin S, Rossi T, Fireman B, et al
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
Vaccine. 2022 May 25. pii: S0264-410X(22)00667.
PubMed Abstract available

BECK E, Biundo E, Devlin N, Doherty TM, et al
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework.
Vaccine. 2022 May 23. pii: S0264-410X(22)00490.
PubMed Abstract available

MALTER KB, Tugel ME, Gil-Rodriguez M, de la Guardia G, et al
Corrigendum to "Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States" [Vaccine 40(7) (2022) 1001-1009].
Vaccine. 2022 May 23. pii: S0264-410X(22)00619.
PubMed

QUINN MK, Edmond KM, Fawzi WW, Hurt L, et al
Non-specific effects of BCG and DTP vaccination on infant mortality: An analysis of birth cohorts in Ghana and Tanzania.
Vaccine. 2022 May 23. pii: S0264-410X(22)00536.
PubMed Abstract available

CHANG CM, Awanye AM, Marsay L, Dold C, et al
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial.
Vaccine. 2022 May 21. pii: S0264-410X(22)00616.
PubMed Abstract available

MOLLER A, Schwamborn K, Spillmann A, Hoogstraate J, et al
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?
Vaccine. 2022 May 21. pii: S0264-410X(22)00611.
PubMed Abstract available

OSMAN S, Crowcroft N, McLachlan E, Hatchette T, et al
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) study.
Vaccine. 2022;40:3228-3235.
PubMed Abstract available

LLAVE CL, Uy MEV, Lam HY, Aldaba JG, et al
The cost-effectiveness of human papillomavirus vaccination in the Philippines.
Vaccine. 2022 May 20. pii: S0264-410X(22)00609.
PubMed Abstract available

FOO D, Sarna M, Pereira G, Moore HC, et al
Maternal influenza vaccination and child mortality: Longitudinal, population-based linked cohort study.
Vaccine. 2022 May 20. pii: S0264-410X(22)00614.
PubMed Abstract available

KITCHEN M, Leierer G, Kistner O, Wodal W, et al
High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
Vaccine. 2022 May 20. pii: S0264-410X(22)00575.
PubMed Abstract available

MCELFISH PA, Selig JP, Scott AJ, Rowland B, et al
Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans.
Vaccine. 2022 May 20. pii: S0264-410X(22)00615.
PubMed Abstract available

SZANYI J, Wilson T, Scott N, Blakely T, et al
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
Vaccine. 2022 May 20. pii: S0264-410X(22)00634.
PubMed Abstract available

SIQUEIRA PG, Duarte HO, Moura MDC
Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer.
Vaccine. 2022 May 19. pii: S0264-410X(22)00633.
PubMed Abstract available

CARSON B, Isaacs J, Carilli T
Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States.
Vaccine. 2022 May 19. pii: S0264-410X(22)00612.
PubMed Abstract available

STEELFISHER GK, Caporello H, McIntosh R, Muhammad Safdar R, et al
Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits and social norms.
Vaccine. 2022 May 19. pii: S0264-410X(22)00567.
PubMed Abstract available

ZHANG Y, Lin L, Yang J, Lv Q, et al
Two Bordetella bronchiseptica attenuated vaccine candidates confer protection against lethal challenge with B. Bronchiseptica and Pasteurella multocida toxin in mouse models.
Vaccine. 2022 May 19. pii: S0264-410X(22)00604.
PubMed Abstract available

POSTMA M, Biundo E, Chicoye A, Devlin N, et al
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts.
Vaccine. 2022 May 18. pii: S0264-410X(22)00442.
PubMed Abstract available

VESIKARI T, Saez-Llorens X, Blazevic V, Lopez P, et al
Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study.
Vaccine. 2022 May 17. pii: S0264-410X(22)00550.
PubMed Abstract available

SALO-TUOMINEN K, Teros-Jaakkola T, Toivonen L, Ollila H, et al
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children.
Vaccine. 2022 May 17. pii: S0264-410X(22)00582.
PubMed Abstract available

ROBERTSON DA, Mohr KS, Barjakova M, Lunn PD, et al
Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruism.
Vaccine. 2022 May 16. pii: S0264-410X(22)00613.
PubMed Abstract available

NAZURDINOV A, Azizov Z, Mullojonova M, Sadykova U, et al
Impact and effectiveness of monovalent rotavirus vaccine in Tajik children.
Vaccine. 2022 May 14. pii: S0264-410X(22)00589.
PubMed Abstract available

SULIS G, Horn M, Borrow R, Basta NE, et al
A comparison of national vaccination policies to prevent serogroup B meningococcal disease.
Vaccine. 2022 May 14. pii: S0264-410X(22)00568.
PubMed Abstract available

POLAND GA, van Dijk N
John D. Bailey retiring after more than 20years of service to Vaccine.
Vaccine. 2022 May 13. pii: S0264-410X(22)00618.
PubMed

CHAMBERS C, Deeks SL, Sutradhar R, Cox J, et al
Increases in human papillomavirus vaccine coverage over 12 months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada.
Vaccine. 2022 May 13. pii: S0264-410X(22)00590.
PubMed Abstract available

KUMAR SURI R, Hayman B, Prasad SD, Makhoana M, et al
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
Vaccine. 2022 May 13. pii: S0264-410X(22)00576.
PubMed Abstract available

DUC DANG A, Dinh Vu T, Hai Vu H, Thanh Ta V, et al
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Vaccine. 2022 May 13. pii: S0264-410X(22)00526.
PubMed Abstract available

TSAI SY, Yeh TY, Chiu NC, Huang CT, et al
National safety surveillance of quadrivalent recombinant influenza vaccine in Taiwan during NH 20/21.
Vaccine. 2022 May 13. pii: S0264-410X(22)00588.
PubMed Abstract available

RUSKIN AC, Rice S, O'Connor M, Ruskin KJ, et al
Effects of vaccination status in the United States on willingness to undergo surgery during a pandemic: A prospective survey study.
Vaccine. 2022 May 13. pii: S0264-410X(22)00583.
PubMed Abstract available

LI F, Freed D, Heidecker G, Galli J, et al
A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments.
Vaccine. 2022 May 13. pii: S0264-410X(22)00569.
PubMed Abstract available

IWATA S, Sonoyama T, Kamitani A, Shibata R, et al
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings.
Vaccine. 2022 May 13. pii: S0264-410X(22)00494.
PubMed Abstract available

ALYA WA, Maraqa B, Nazzal Z, Odeh M, et al
COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality.
Vaccine. 2022 May 13. pii: S0264-410X(22)00610.
PubMed Abstract available

MANCARELLA M, Natarelli F, Bertolini C, Zagari A, et al
Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy.
Vaccine. 2022 May 12. pii: S0264-410X(22)00573.
PubMed Abstract available

CUMMINS NW, Badley AD
Could proteasome inhibition improve therapeutic vaccine response in HIV?
Vaccine. 2022 May 12. pii: S0264-410X(22)00578.
PubMed

CHONG-VALBUENA A, De-Jesus-Maria I, Agurto-Ramirez A, Puchades-Gimeno F, et al
Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: Differences between naive and previously infected by SARS-CoV-2.
Vaccine. 2022 May 12. pii: S0264-410X(22)00586.
PubMed Abstract available

OSTER G, Bornheimer R, Ottino K, Stevenson C, et al
Adult immunization against hepatitis B: Does the number of jabs matter?
Vaccine. 2022 May 12. pii: S0264-410X(22)00534.
PubMed Abstract available

TEASDALE CA, Ratzan S, Stuart Lathan H, Rauh L, et al
Acceptability of COVID-19 vaccine mandates among New York City parents, November 2021.
Vaccine. 2022 May 11. pii: S0264-410X(22)00580.
PubMed Abstract available

SHAUM A, Mujuru HA, Takamiya M, Ticklay I, et al
Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe.
Vaccine. 2022 May 11. pii: S0264-410X(22)00551.
PubMed Abstract available

FERNANDES C, Alves J, Rodrigues A, Azevedo J, et al
Corrigendum to "Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study" [Vaccine 40(2) (2022) 275-281].
Vaccine. 2022 May 11. pii: S0264-410X(22)00537.
PubMed

ISLAM N, Xu C, Lau CL, Mills DJ, et al
Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis.
Vaccine. 2022 May 11. pii: S0264-410X(22)00535.
PubMed Abstract available

GUPTA C, Sachdeva A, Khamar J, Bu C, et al
Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis.
Vaccine. 2022 May 10. pii: S0264-410X(22)00468.
PubMed Abstract available

KITRO A, Sirikul W, Thongkum W, Soponpong S, et al
Dynamic of anti-spike receptor binding domain (RBD) levels and short-term adverse events following a heterologous booster dose of BNT162b2 after two doses of CoronaVac in Thai health care workers.
Vaccine. 2022;40:2915-2924.
PubMed Abstract available

MARTIN J, Barrett ADT, Lei D, Minor P, et al
WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines.
Vaccine. 2022 May 9. pii: S0264-410X(22)00548.
PubMed Abstract available

ZOLA MATUVANGA T, Lariviere Y, Lemey G, De Bie J, et al
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Vaccine. 2022 May 9. pii: S0264-410X(22)00544.
PubMed Abstract available

YI S, Choe YJ, Lim DS, Lee HR, et al
Impact of national Covid-19 vaccination Campaign, South Korea.
Vaccine. 2022 May 8. pii: S0264-410X(22)00572.
PubMed Abstract available

BIFULCO M, Di Zazzo E, Pisanti S, Martini M, et al
The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: An Italian phenomenon?
Vaccine. 2022 May 6. pii: S0264-410X(22)00492.
PubMed Abstract available

CROTHERS JW, Ross Colgate E, Cowan KJ, Dickson DM, et al
Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus sero
Vaccine. 2022 May 6. pii: S0264-410X(22)00571.
PubMed

LUMBRERAS ARETA M, Valiton A, Diana A, Morales M, et al
Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study.
Vaccine. 2022 May 6. pii: S0264-410X(22)00533.
PubMed Abstract available

YU Y, Ma YL, Luo S, Wang S, et al
Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China.
Vaccine. 2022 May 5. pii: S0264-410X(22)00532.
PubMed Abstract available

COLE JW, Chen AMH, McGuire K, Berman S, et al
Erratum to "Motivational interviewing and vaccine acceptance in children: The MOTIVE study" [Vaccine 40(12) (2022) 1846-1854].
Vaccine. 2022 May 5. pii: S0264-410X(22)00538.
PubMed

VELICER C, Luxembourg A, Chen YT, Kohn M, et al
Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection.
Vaccine. 2022 May 5. pii: S0264-410X(22)00542.
PubMed

NAULT L, Marchitto L, Goyette G, Tremblay-Sher D, et al
Covid-19 vaccine immunogenicity in people living with HIV-1.
Vaccine. 2022 May 5. pii: S0264-410X(22)00543.
PubMed Abstract available

GASTEIGER N, Gasteiger C, Vedhara K, Broadbent E, et al
Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach.
Vaccine. 2022 May 5. pii: S0264-410X(22)00547.
PubMed Abstract available

REES F, Geiger M, Lilleholt L, Zettler I, et al
Measuring parents' readiness to vaccinate themselves and their children against COVID-19.
Vaccine. 2022 May 5. pii: S0264-410X(22)00549.
PubMed Abstract available

LEIGH JP, Moss SJ, White TM, Picchio CA, et al
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries.
Vaccine. 2022 May 5. pii: S0264-410X(22)00545.
PubMed Abstract available

PERSSON U, Olofsson S, Althin R, Palmborg A, et al
Acceptance and application of a broad population health perspective when evaluating vaccine.
Vaccine. 2022 May 4. pii: S0264-410X(22)00425.
PubMed Abstract available

LIU W, Lien YH, Lee PI, Chan TC, et al
Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
Vaccine. 2022 May 4. pii: S0264-410X(22)00358.
PubMed Abstract available

GUTIERREZ-TOBAR IF, Londono-Ruiz JP, Marino-Drews C, Beltran-Higuera S, et al
Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008-2019.
Vaccine. 2022;40:2875-2883.
PubMed Abstract available

BOTHUN LS, Feeder SE, Poland GA
Readability of COVID-19 vaccine information for the general public.
Vaccine. 2022 May 3. pii: S0264-410X(22)00546.
PubMed Abstract available

NANTANEE R, Aikphaibul P, Jaru-Ampornpan P, Sodsai P, et al
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac.
Vaccine. 2022 May 2. pii: S0264-410X(22)00521.
PubMed Abstract available

FEIKIN DR, Abu-Raddad LJ, Andrews N, Davies MA, et al
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization.
Vaccine. 2022 May 2. pii: S0264-410X(22)00523.
PubMed Abstract available

April 2022

TOLL M, Li A
Vaccine mandates on childcare entry without conscientious objection exemptions: A quasi-experimental panel study.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00461.
PubMed Abstract available

GREYSON D, Carpiano RM, Bettinger JA
Support for a vaccination documentation mandate in British Columbia, Canada.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00247.
PubMed Abstract available

TAMURA K, Kohnoe M, Takashino A, Kobayashi K, et al
TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00518.
PubMed Abstract available

MASUDA T, Murakami K, Sugiura K, Sakui S, et al
Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00463.
PubMed Abstract available

HUSSAIN B, Latif A, Timmons S, Nkhoma K, et al
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies.
Vaccine. 2022 Apr 28. pii: S0264-410X(22)00446.
PubMed Abstract available

DEMIR E, Dheir H, Safak S, Serra Artan A, et al
Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00519.
PubMed Abstract available

TAMURA K, Chang B, Shimbashi R, Watanabe H, et al
Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00502.
PubMed Abstract available

NASREEN S, Calzavara A, Buchan SA, Thampi N, et al
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00520.
PubMed Abstract available

LV H, Wang S, Liang Z, Yu W, et al
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9-45 years of age: A phase 3 open-label study.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00205.
PubMed Abstract available

MARKOVITZ NH, Strome AL, Patel PK
Commentary: "The vaccine Selfie" and its influence on COVID-19 vaccine acceptance.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00503.
PubMed

JAFFLIN K, Deml MJ, Schwendener CL, Kiener L, et al
Parental and provider vaccine hesitancy and non-timely childhood vaccination in Switzerland.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00472.
PubMed Abstract available

KOULIDIATI JL, Kabore R, I Nebie E, Sidibe A, et al
Timely completion of childhood vaccination and its predictors in Burkina Faso.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00497.
PubMed Abstract available

MCCOSKER LK, El-Heneidy A, Seale H, Ware RS, et al
Strategies to improve vaccination rates in people who are homeless: A systematic review.
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00436.
PubMed Abstract available

KRUPP K, Galea J, Madhivanan P, Gerald L, et al
Conversational artificial intelligence: A new approach for increasing influenza vaccination rates in children with asthma?
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00496.
PubMed

YUKI Y, Nojima M, Kashima K, Sugiura K, et al
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00491.
PubMed Abstract available

ZHU FC, Zeng H, Li JX, Wang B, et al
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00462.
PubMed Abstract available

PERCIACCANTE A, Asensi V, Cucu AI, Charlier P, et al
War, pandemic and vaccination - Upcoming health problems by the refugee wave in Europe?
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00465.
PubMed

BEYER WEP, Palache AM, Boulfich M, Osterhaus ADME, et al
Clinical relevance of increased antibody titres in older adults upon vaccination with squalene-adjuvanted versus non-adjuvanted influenza vaccines.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00489.
PubMed Abstract available

STRECKENBACH B, Baldt J, Heidler F, Frahm N, et al
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00428.
PubMed Abstract available

ONNIS V, Moriconi A, Paludi M, Giannini S, et al
Clinically proven specification setting for a meningococcal serogroup a conjugate vaccine.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00493.
PubMed Abstract available

ANTONOPOULOU T, Athanassakis I
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00501.
PubMed

SHEA LL, Becker A, Lee BK, Miller KK, et al
Self-reported COVID-19 vaccination acceptance and hesitancy among autistic adults.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00500.
PubMed Abstract available

HAMID FA, Marker CL, Raleigh MD, Khaimraj A, et al
Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00364.
PubMed Abstract available

SEPPALA E, Brathen Kristoffersen A, Boas H, Frimann Vestrheim D, et al
Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998-2019.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00466.
PubMed Abstract available

BEULENS C, Raven SFH, van Jaarsveld CHM, van Loo I, et al
Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00470.
PubMed Abstract available

STALPERS CAL, Retmana IA, Pennings JLA, Vandebriel RJ, et al
Corrigendum to "Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines" [Vaccine 39(18) (2021) 2506-2516].
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00475.
PubMed

SALO H, Lehtonen T, Auranen K, Baum U, et al
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00495.
PubMed Abstract available

TAMANG ST, Dorji T
COVID-19 vaccinations in Bhutan - Mix-and-Match to Boosters: An experience.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00499.
PubMed Abstract available

ORTIZ JR, Spearman PW, Goepfert PA, Cross K, et al
Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial.
Vaccine. 2022 Apr 21. pii: S0264-410X(22)00366.
PubMed Abstract available

CAN G, Acar HC, Aydin SN, Balkan II, et al
Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers.
Vaccine. 2022;40:2574-2579.
PubMed Abstract available

LEBLANC JJ, ElSherif M, Ye L, MacKinnon-Cameron D, et al
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay.
Vaccine. 2022;40:2635-2646.
PubMed Abstract available

THOMPSON D, Metz SW, Abad C, Beaty S, et al
Immunological implications of diverse production approaches for Chikungunya virus-like particle vaccines.
Vaccine. 2022 Apr 19. pii: S0264-410X(22)00435.
PubMed Abstract available

GARTNER BC, Weinke T, Wahle K, Kwetkat A, et al
Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective - A systematic review of recently published literature on real-world data.
Vaccine. 2022 Apr 19. pii: S0264-410X(22)00440.
PubMed Abstract available

LI L, Honda-Okubo Y, Baldwin J, Bowen R, et al
Covax-19/Spikogen(R) vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00469.
PubMed Abstract available

WANLAPAKORN N, Suntronwong N, Phowatthanasathian H, Yorsaeng R, et al
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00471.
PubMed Abstract available

SAADE A, Cha L, Tadie E, Jurado B, et al
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00473.
PubMed Abstract available

CHRISSIAN AA, Oyoyo UE, Patel P, Lawrence Beeson W, et al
Impact of COVID-19 vaccine-associated side effects on health care worker absenteeism and future booster vaccination.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00474.
PubMed Abstract available

XU S, Hong V, Sy LS, Glenn SC, et al
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00464.
PubMed Abstract available

SINGH BK, Walker J, Paul P, Reddy S, et al
De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in US nursing homes amidst rising community vaccination coverage: A modeling study.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00467.
PubMed Abstract available

ANDERSON A
Attitudes towards vaccination and knowledge about antibiotics: Analysis of Wellcome Monitor survey data.
Vaccine. 2022 Apr 15. pii: S0264-410X(22)00429.
PubMed Abstract available

BAROUTSOU V, Wymann M, Zens K, Sinniger P, et al
National and regional variations in timely adherence to recommended measles vaccination scheme in 2-years old in Switzerland, 2005-2019.
Vaccine. 2022 Apr 15. pii: S0264-410X(22)00424.
PubMed Abstract available

KUSHNER T, Huang V, Janssen R
Safety and immunogenicity of HepB-CpG in women with documented pregnancies post-vaccination: A retrospective chart review.
Vaccine. 2022 Apr 13. pii: S0264-410X(22)00443.
PubMed Abstract available

FENOLLAR F, Thomas L, Raoult D, Gautret P, et al
Screening for SARS-CoV-2 antibodies to save vaccine doses.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00444.
PubMed

YAN Y, Naito T, Tabe Y, Ito K, et al
Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00445.
PubMed Abstract available

BRAEYE T, Catteau L, Brondeel R, van Loenhout JAF, et al
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00441.
PubMed Abstract available

MORO PL, Olson CK, Clark E, Marquez P, et al
Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00447.
PubMed Abstract available

ZHU XM, Yan W, Sun J, Liu L, et al
Patterns and influencing factors of COVID-19 vaccination willingness among college students in China.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00433.
PubMed Abstract available

SHINJOH M, Furuichi M, Kobayashi H, Yamaguchi Y, et al
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00449.
PubMed Abstract available

SPRINGER S, Kaatz M, Zieger M
Evaluation of weekly COVID-19 vaccination and case data supports negative correlation between incidence and vaccination in German federal states and cities during 4th wave.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00430.
PubMed Abstract available

CEYLAN ME, Onen Unsalver B, Donmez A, Kaya Yertutanol FD, et al
A case of myocarditis and isolated hypopotassemia after Biontech-Pfizer vaccine for Covid-19.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00432.
PubMed

LJUNG R, Feychting M, Burstrom B, Moller J, et al
Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00431.
PubMed Abstract available

OKTARIA V, Bines JE, Murni IK, Dinari R, et al
Timeliness of routine childhood vaccinations in Indonesian infants in the first year of life.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00420.
PubMed Abstract available

BENINGER P
Need for a contingency dimension when planning vaccine development in a pandemic environment.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00401.
PubMed

PARK SJ, Kang YM, Cho HK, Kim DY, et al
Corrigendum to 'Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice' [Vaccine 39 (2021) 6213-6220].
Vaccine. 2022 Apr 9. pii: S0264-410X(22)00221.
PubMed

AINSLIE KEC, Riley S
Is annual vaccination best? A modelling study of influenza vaccination strategies in children.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00384.
PubMed Abstract available

TIANSHUO Z, Hanyu L, Bingfeng H, Bei L, et al
Evaluation of the reliability and validity of a vaccine hesitancy scale on knowledge, attitude, trust and vaccination environment (KATE-S) in Chinese parents.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00388.
PubMed Abstract available

MAYFIELD HJ, Lau CL, Sinclair JE, Brown SJ, et al
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00418.
PubMed Abstract available

BELDA F, Mora O, Lopez Martinez M, Torres N, et al
Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00419.
PubMed Abstract available

ERFANI P, Sandoval RS, Rich KM, Ojo A, et al
Ask Me Anything": Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jails.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00439.
PubMed Abstract available

KENIGSBERG TA, Hause AM, McNeil MM, Nelson JC, et al
Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the vaccine safety datalink.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00426.
PubMed Abstract available

LINKINS LA, Iorio A, Little J, Lavis J, et al
Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00422.
PubMed

DE-LOS-RIOS-PINTO A, Fernandez-Guzman D, Soriano-Moreno DR, Sangster-Carrasco L, et al
Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00421.
PubMed Abstract available

SHAH S, Gui H, Chua PEY, Tan JB, et al
Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong.
Vaccine. 2022 Apr 5. pii: S0264-410X(22)00381.
PubMed Abstract available

HASSAN PM, Ali T, Saber E, Asghar A, et al
Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00385.
PubMed Abstract available

LEWIS RM, Markowitz LE
Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017-March 2020.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00317.
PubMed Abstract available

WALTERS JN, Schouest B, Patel A, Reuschel EL, et al
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00368.
PubMed Abstract available

ENTRICAN G, Francis MJ
Applications of platform technologies in veterinary vaccinology and the benefits for one health.
Vaccine. 2022 Apr 2. pii: S0264-410X(22)00371.
PubMed Abstract available

FRISE R, Baillon L, Zhou J, Kugathasan R, et al
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00383.
PubMed Abstract available

MA C, Sun W, Tang T, Jia M, et al
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00386.
PubMed Abstract available

SUGHAYER MA, Souan L, Abu Alhowr MM, Al Rimawi D, et al
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00387.
PubMed Abstract available

March 2022

GERTOSIO C, Licari A, De Silvestri A, Rebuffi C, et al
Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis.
Vaccine. 2022 Mar 31. pii: S0264-410X(22)00341.
PubMed Abstract available

TEJADA RA, Malagon T, Franco EL
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis.
Vaccine. 2022 Mar 31. pii: S0264-410X(22)00357.
PubMed Abstract available

VANDOORN E, Parys A, Chepkwony S, Chiers K, et al
Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00362.
PubMed Abstract available

BURNY W, Herve C, Caubet M, Yarzabal JP, et al
Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00361.
PubMed Abstract available

CROTHERS JW, Ross Colgate E, Cowan KJ, Dickson DM, et al
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a rando
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00367.
PubMed Abstract available

EFUA SACKEY M, Markey K, Grealish A
Healthcare professional's promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00365.
PubMed Abstract available

TADDIO A, Gudzak V, Jantzi M, Logeman C, et al
Impact of the CARD (Comfort Ask Relax Distract) system on school-based vaccinations: A cluster randomized trial.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00224.
PubMed Abstract available

MCRAE J, Blyth CC, Cheng AC, Quinn HE, et al
Preventing severe influenza in Australian infants: Maternal influenza vaccine effectiveness in the PAEDS-FluCAN networks using the test-negative design.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00353.
PubMed

ESTIVARIZ CF, Kovacs SD, Mach O
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00304.
PubMed Abstract available

ISITT C, Sjoholm D, Hergens MP, Granath F, et al
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00372.
PubMed Abstract available

KATO H, Miyakawa K, Ohtake N, Yamaoka Y, et al
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00369.
PubMed Abstract available

LI K, Yu T, Seabury SA, Dor A, et al
Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00370.
PubMed Abstract available

JUDDOO V, Juddoo S, Megarbane B
Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00363.
PubMed

BREAKWELL L, Marke D, Kaiser R, Tejada-Strop A, et al
Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00360.
PubMed Abstract available

FUNK PR, Yogurtcu ON, Forshee RA, Anderson SA, et al
Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00329.
PubMed Abstract available

WELLS K, Moore KL, Bednarczyk R
Supporting immunization programs to address COVID-19 vaccine hesitancy: Recommendations for national and community-based stakeholders.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00339.
PubMed

RICKETSON LJ, Bettinger JA, Sadarangani M, Halperin SA, et al
Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study.
Vaccine. 2022 Mar 26. pii: S0264-410X(22)00359.
PubMed Abstract available

SIMMONS LA, Whipps MDM, Phipps JE, Satish NS, et al
Understanding COVID-19 vaccine uptake during pregnancy: 'Hesitance', knowledge, and evidence-based decision-making.
Vaccine. 2022 Mar 25. pii: S0264-410X(22)00355.
PubMed Abstract available

FARAH W, Breeher L, Shah V, Hainy C, et al
Disparities in COVID-19 vaccine uptake among health care workers.
Vaccine. 2022 Mar 25. pii: S0264-410X(22)00356.
PubMed Abstract available

NOMURA Y, Noda K, Oohashi Y, Okuda S, et al
Proposal for the revision of the guidelines for Non-clinical studies of vaccines for the prevention of infectious diseases in Japan.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00354.
PubMed Abstract available

NANTHAPISAL S, Puthanakit T, Jaru-Ampornpan P, Nantanee R, et al
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00336.
PubMed Abstract available

ST JEAN DT, Rogawski McQuade ET, Edwards JK, Thompson P, et al
Effect of early life antibiotic use on serologic responses to oral rotavirus vaccine in the MAL-ED birth cohort study.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00300.
PubMed Abstract available

LEACH K, Checchi F
The utilisation of vaccines in humanitarian crises, 2015-2019: A review of practice.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00335.
PubMed Abstract available

VOORMAN A, Lyons H, Bennette C, Kovacs S, et al
Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00277.
PubMed Abstract available

LIU X, Yu W, Yin Z, Rodewald L, et al
Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00334.
PubMed Abstract available

ABDEL-QADER DH, Hazza Alkhatatbeh I, Hayajneh W, Annab H, et al
IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00265.
PubMed

SNIDER CJ, Boualam L, Tallis G, Takashima Y, et al
Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021.
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00145.
PubMed Abstract available

MALTEZOU HC, Medic S, Cassimos DC, Effraimidou E, et al
Decreasing routine vaccination rates in children in the COVID-19 era.
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00333.
PubMed

FANO V, Crielesi A, Coviello E, Fabiani M, et al
Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy).
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00208.
PubMed Abstract available

FERDINANDS JM, Patel M
Influence of disease attenuation on relative influenza vaccine effectiveness by vaccine type.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00274.
PubMed Abstract available

JIAN-BIN L, Lau EYH, Chan DKC
Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00340.
PubMed Abstract available

YUEN WLP, Loh SYJ, Wang DB
SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00337.
PubMed Abstract available

ZERBO O, Modaressi S, Goddard K, Lewis E, et al
Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00331.
PubMed Abstract available

CALLAGHAN T, Washburn D, Goidel K, Nuzhath T, et al
Imperfect messengers? An analysis of vaccine confidence among primary care physicians.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00302.
PubMed Abstract available

ESPOSITO S, Nauta J, Lapini G, Montomoli E, et al
Efficacy and safety of a quadrivalent influenza vaccine in children aged 6-35 months: A global, multiseasonal, controlled, randomized Phase III study.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00263.
PubMed Abstract available

BILGIN H, Marku M, Yilmaz SS, Karahasan Yagci A, et al
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-gamma release by natural killer cells.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00264.
PubMed Abstract available

GRUHN S, Witte J, Greiner W, Damm O, et al
Epidemiology and economic burden of meningococcal disease in Germany: A systematic review.
Vaccine. 2022;40:1932-1947.
PubMed Abstract available

WANG H, Ypma E, Nicolay U
Managing multiplicity in clinical vaccine studies - A case study using a gatekeeping testing strategy.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00244.
PubMed Abstract available

GRAFFIGNA G, Palamenghi L, Barello S, Boccia S, et al
Erratum to ""Cultivating" acceptance of a COVID-19 vaccination program: Lessons from Italy" [Vaccine 38(48) (2020) 7585-7586].
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00295.
PubMed

BATOOL R, Yousafzai MT, Qureshi S, Ali M, et al
Corrigendum to "Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study". [Vaccine 39 (2021) 5858-5865].
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00294.
PubMed

MACKLIN G, Peak C, Eisenhawer M, Kurji F, et al
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00195.
PubMed Abstract available

SADIGH K, Fox G, Khetsuriani N, Gao H, et al
Policy and practice of checking vaccination status at school in 2018, a global overview.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00266.
PubMed Abstract available

GAO Z, Chen L, Song T, Pan X, et al
A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00296.
PubMed Abstract available

GUL A, Doskaya M, Can H, Karakavuk M, et al
Immunogenicity of a xenogeneic multi-epitope HER2(+) breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205.
Vaccine. 2022 Mar 16. pii: S0264-410X(22)00279.
PubMed Abstract available

BEESLAAR J, Mather S, Absalon J, Eiden JJ, et al
Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older.
Vaccine. 2022;40:1872-1878.
PubMed Abstract available

KHETSURIANI N, Zaika O, Slobodianyk L, Scobie HM, et al
Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017.
Vaccine. 2022;40:1810-1820.
PubMed Abstract available

CAMARA J, Gonzalez-Diaz A, Barrabeig I, Fernandez-Huerta M, et al
SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: A role for the quantification of circulating antibodies.
Vaccine. 2022 Mar 15. pii: S0264-410X(22)00303.
PubMed Abstract available

ROTOLO B, Dube E, Vivion M, MacDonald SE, et al
Hesitancy towards COVID-19 vaccines on social media in Canada.
Vaccine. 2022 Mar 15. pii: S0264-410X(22)00301.
PubMed Abstract available

MOSCARDINO U, Musso P, Inguglia C, Ceccon C, et al
Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy.
Vaccine. 2022 Mar 14. pii: S0264-410X(22)00293.
PubMed Abstract available

MORGA A, Kimura T, Feng Q, Rozario N, et al
Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination.
Vaccine. 2022 Mar 12. pii: S0264-410X(22)00269.
PubMed Abstract available

LAMORI J, Feng X, Pericone CD, Mesa-Frias M, et al
Real-world evidence on adherence and completion of the two-dose recombinant zoster vaccine and associated factors in U.S. adults, 2017-2021.
Vaccine. 2022 Mar 12. pii: S0264-410X(22)00268.
PubMed Abstract available

HUANG HJ, Yang M, Chen HW, Wang S, et al
A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
Vaccine. 2022 Mar 11. pii: S0264-410X(22)00225.
PubMed Abstract available

GU YOON J, Jang AY, Ja Kim M, Bin Seo Y, et al
Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibility.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00267.
PubMed Abstract available

KAKATSAKI I, Vergadi E, Paraskakis E, Galanakis E, et al
Attitudes of junior healthcare professionals towards mandatory vaccination.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00275.
PubMed Abstract available

HARUTYUNYAN V, Quddus A, Pallansch M, Zipursky S, et al
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00204.
PubMed Abstract available

VAN DEN HOOGEN LL, Smits G, van Hagen CCE, Wong D, et al
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
Vaccine. 2022 Mar 9. pii: S0264-410X(22)00272.
PubMed Abstract available

THOMAS CM, Searle K, Galvan A, Liebman AK, et al
Healthcare worker perspectives on COVID-19 vaccines: Implications for increasing vaccine acceptance among healthcare workers and patients.
Vaccine. 2022 Mar 9. pii: S0264-410X(22)00276.
PubMed Abstract available

WILKINSON K, Righolt CH, Kwong JC, Schwartz KL, et al
Corrigendum to "A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study" [Vaccine 37(48) (2019) 7132-7137].
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00240.
PubMed

YUEN VWH
Political attitudes and efficacy of health expert communication on the support for COVID-19 vaccination program: Findings from a survey in Hong Kong.
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00261.
PubMed Abstract available

BANSAL P, Raj A, Mani Shukla D, Sunder N, et al
COVID-19 vaccine preferences in India.
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00241.
PubMed Abstract available

ULRICH AK, Sundaram ME, Basta NE
Supporting individual vaccine decision-making: A role for vaccination counselors.
Vaccine. 2022 Mar 4. pii: S0264-410X(22)00135.
PubMed

MASCHERINI M, Nivakoski S
Social media use and vaccine hesitancy in the European Union.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00206.
PubMed Abstract available

KLUMPP M, Monfared IG, Vollmer S
Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00259.
PubMed Abstract available

COULAUD PJ, Ablona A, Bolduc N, Fast D, et al
COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00260.
PubMed Abstract available

ROBERTSON LJ, Price R, Moore JS, Curry G, et al
IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00262.
PubMed Abstract available

KREPS SE, Kriner DL
How do COVID-19 vaccine mandates affect attitudes toward the vaccine and participation in mandate-affected activities? Evidence from the United States.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00258.
PubMed Abstract available

WONDIMU A, Postma MJ, van Hulst M
Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00245.
PubMed Abstract available

YU M, Yao X, Liu G, Wu J, et al
Barriers and facilitators to uptake and promotion of influenza vaccination among health care workers in the community in Beijing, China: A qualitative study.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00207.
PubMed Abstract available

POINTON L, Howe AS, Hobbs M, Paynter J, et al
Evidence of suboptimal maternal vaccination coverage in pregnant New Zealand women and increasing inequity over time: A nationwide retrospective cohort study.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00243.
PubMed Abstract available

LAI FTT, Leung MTY, Chan EWW, Huang L, et al
Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring.
Vaccine. 2022;40:1390-1396.
PubMed Abstract available

DENNY L
HPV vaccine introduction and implementation in LMICs.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00227.
PubMed

GU J, Dor A, Li K, Broniatowski DA, et al
The impact of Facebook's vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00209.
PubMed Abstract available

SEXSON TEJTEL SK, Munoz FM, Al-Ammouri I, Savorgnan F, et al
Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2022;40:1499-1511.
PubMed Abstract available

MOURA C, Truche P, Sousa Salgado L, Meireles T, et al
The impact of COVID-19 on routine pediatric vaccination delivery in Brazil.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00242.
PubMed Abstract available

February 2022

SINGH JA, Kochhar S, Wolff J, Atuire C, et al
WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations.
Vaccine. 2022 Feb 28. pii: S0264-410X(22)00175.
PubMed Abstract available

MCANDREW T, Cambeiro J, Besiroglu T
Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine.
Vaccine. 2022 Feb 28. pii: S0264-410X(22)00200.
PubMed Abstract available

LAU YL, Fan Leung T, Sirvan Cetin B, Cagri Dinleyici E, et al
Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00218.
PubMed Abstract available

SALIOU P, Duteil Q, Plotkin SA, Gentilini M, et al
The scourge of vaccine falsification.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00119.
PubMed Abstract available

SCHAFER W, Reinders T, Schink T
Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00222.
PubMed Abstract available

DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00220.
PubMed Abstract available

KAGEYAMA T, Tanaka S, Etori K, Hattori K, et al
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2.
Vaccine. 2022 Feb 25. pii: S0264-410X(22)00192.
PubMed Abstract available

MULLER KE, Dohos D, Sipos Z, Kiss S, et al
Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients.
Vaccine. 2022 Feb 25. pii: S0264-410X(22)00163.
PubMed Abstract available

MCGOLDRICK M, Gastineau T, Wilkinson D, Campa C, et al
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation.
Vaccine. 2022;40:1223-1230.
PubMed Abstract available

MCGOLDRICK M, Gastineau T, Wilkinson D, Campa C, et al
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation.
Vaccine. 2022;40:1215-1222.
PubMed Abstract available

DIXON MG, Tapia MD, Wannemuehler K, Luce R, et al
Measles susceptibility in maternal-infant dyads-Bamako, Mali.
Vaccine. 2022;40:1316-1322.
PubMed Abstract available

HAO F, Shao W
Understanding the influence of political orientation, social network, and economic recovery on COVID-19 vaccine uptake among Americans.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00219.
PubMed Abstract available

NIE J, Sun Y, Feng K, Huang L, et al
The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00159.
PubMed Abstract available

EL-HENEIDY A, Grimwood K, Lambert SB, Sarna M, et al
Association between vaccination status, symptom identification and healthcare use: Implications for test negative design observational studies.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00198.
PubMed Abstract available

ABBATECOLA AM, Incalzi RA, Malara A, Palmieri A, et al
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00217.
PubMed Abstract available

CHOOI WH, Ng PW, Hussain Z, Ming LC, et al
Vaccine contamination: Causes and control.
Vaccine. 2022 Feb 21. pii: S0264-410X(22)00169.
PubMed

TAWINPRAI K, Siripongboonsitti T, Porntharukchareon T, Wittayasak K, et al
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial
Vaccine. 2022 Feb 21. pii: S0264-410X(22)00143.
PubMed Abstract available

ISMAIL ALHOSANI F, Eduardo Stanciole A, Aden B, Timoshkin A, et al
Impact of the Sinopharm's BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE).
Vaccine. 2022 Feb 19. pii: S0264-410X(22)00174.
PubMed Abstract available

FILIA A, Rota MC, Grossi A, Martinelli D, et al
Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.
Vaccine. 2022 Feb 19. pii: S0264-410X(22)00187.
PubMed Abstract available

WINTER T, Riordan BC, Scarf D, Jose PE, et al
Conspiracy beliefs and distrust of science predicts reluctance of vaccine uptake of politically right-wing citizens.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00074.
PubMed Abstract available

STANDAERT B, Strens D, Raes M, Benninghoff B, et al
Explaining the formation of a plateau in rotavirus vaccine impact on rotavirus hospitalisations in Belgium.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00199.
PubMed Abstract available

LEE GY, Inthasorn P, Laowahutanont P, Lawpoolsri S, et al
Long-term effectiveness of human papillomavirus vaccines among adult women: A real-world scenario.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00188.
PubMed Abstract available

SCHMALING KB
Couples and COVID-19 vaccination: Frequency and reasons for discordance.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00202.
PubMed Abstract available

TRUMP BD, Golan MS, Keisler JM, Cegan JC, et al
Vaccine supply chain: Resilience-by-design and resilience-by-intervention.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00172.
PubMed

HENSCHKE N, Bergman H, Hungerford D, Cunliffe NA, et al
The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00125.
PubMed Abstract available

KASSTAN B, Mounier-Jack S, Letley L, Gaskell KM, et al
Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00201.
PubMed Abstract available

MERKLEY E, Loewen PJ
The correlates and dynamics of COVID-19 vaccine-specific hesitancy.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00168.
PubMed Abstract available

LAZO L, Bequet-Romero M, Lemos G, Musacchio A, et al
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice.
Vaccine. 2022;40:1162-1169.
PubMed Abstract available

JOG P, Memon IA, Thisyakorn U, Hozbor D, et al
Pertussis in Asia: Recent country-specific data and recommendations.
Vaccine. 2022;40:1170-1179.
PubMed Abstract available

STEFANIZZI P, Larocca AMV, Martinelli A, Soldano S, et al
Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00124.
PubMed Abstract available

KALASKA B, Miklosz J, Swieton J, Jakimczuk A, et al
The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00173.
PubMed Abstract available

BUCKLEY A, Lager K
Efficacy of an inactivated Senecavirus A vaccine in weaned pigs and mature sows.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00142.
PubMed Abstract available

ANUGULRUENGKITT S, Angsuwatcharakon P, Puthanakit T, Bunjoungmanee P, et al
Seroprevalence of mumps among children and adolescents in Thailand, 2020.
Vaccine. 2022;40:1061-1064.
PubMed Abstract available

HUSKA B, Kubinec C, Sadarangani M, Ulanova M, et al
Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children.
Vaccine. 2022;40:1128-1134.
PubMed Abstract available

ARAKELIAN T, Oosterhuis K, Tondini E, Los M, et al
Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00162.
PubMed Abstract available

SALEH OA, Halperin O
Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00160.
PubMed Abstract available

HIDLE A, Brennan T, Garon J, An Q, et al
Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00047.
PubMed Abstract available

QUITIAN LM, Rodriguez-Martinez CE, Sossa-Briceno MP, Cortes JA, et al
Disease burden and vaccination priorities in Colombia.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00029.
PubMed Abstract available

TANI N, Chong Y, Kurata Y, Gondo K, et al
Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00158.
PubMed Abstract available

AMMETER T, Lang P, Czock A
Overview of the influenza vaccination activities and legal frameworks in 26 Swiss cantons during the influenza season 2019/20.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00132.
PubMed Abstract available

MUCHIRI SK, Muthee R, Kiarie H, Sitienei J, et al
Unmet need for COVID-19 vaccination coverage in Kenya.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00167.
PubMed Abstract available

GAFFNEY KK, Jana Broadhurst M, Brett-Major DM
Mumps to COVID-19: Vaccinated persons remain vulnerable when community uptake is low.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00193.
PubMed Abstract available

YAMAMOTO S, Fukunaga A, Tanaka A, Takeuchi JS, et al
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00196.
PubMed Abstract available

UWAMINO Y, Yokoyama T, Shimura T, Nishimura T, et al
The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00191.
PubMed Abstract available

GAO F, An C, Bian L, Wang Y, et al
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00194.
PubMed Abstract available

CHAN IL, Mowson R, Alonso JP, Roberti J, et al
Promoting immunization equity in Latin America and the Caribbean: Case studies, lessons learned, and their implication for COVID-19 vaccine equity.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00197.
PubMed Abstract available

CHRYSI P, Stella M, Marios K, Despo C, et al
Exploring vaccination coverage and attitudes of health care workers towards influenza vaccine in Cyprus.
Vaccine. 2022 Feb 12. pii: S0264-410X(22)00141.
PubMed Abstract available

HELLER O, Chun Y, Shlomo Y, Gewirtz-Meydan A, et al
Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00165.
PubMed Abstract available

KOCHHAR S, Barreira D, Beattie P, Cavaleri M, et al
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Vaccine. 2022 Feb 11. pii: S0264-410X(21)01395.
PubMed Abstract available

DIETRICH LG, Luthy A, Lucas Ramanathan P, Baldesberger N, et al
Healthcare professional and professional stakeholders' perspectives on vaccine mandates in Switzerland: A mixed-methods study.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00007.
PubMed Abstract available

TIBBELS NJ, Dosso A, Fordham C, Benie W, et al
"On the last day of the last month, I will go": A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00166.
PubMed Abstract available

KAPLONEK P, Yao L, Reppe K, Voss F, et al
A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae.
Vaccine. 2022;40:1038-1046.
PubMed Abstract available

ABHILASH KPP, Mathiyalagan P, Krishnaraj VRK, Selvan S, et al
Impact of prior vaccination with Covishield(TM) and Covaxin(R) on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00157.
PubMed Abstract available

DEBELLUT F, Mkisi R, Masoo V, Chisema M, et al
Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00139.
PubMed Abstract available

COLE JW, M H Chen A, McGuire K, Berman S, et al
Motivational interviewing and vaccine acceptance in children: The MOTIVE study.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00114.
PubMed Abstract available

PAOLINO KM, Regules JA, Moon JE, Ruck RC, et al
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00093.
PubMed Abstract available

BERGMANN ESTEVES S, Moreira Santos C, Ferreira Salgado F, Paldes Goncales A, et al
Efficacy of commercially available vaccines against canine leptospirosis: A systematic review and meta-analysis.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00144.
PubMed Abstract available

DREYER N, Reynolds MW, Albert L, Brinkley E, et al
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00103.
PubMed Abstract available

PRAMOD S, Govindan D, Ramasubramani P, Kar SS, et al
Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study.
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00138.
PubMed Abstract available

DE LUCA C, Schachner A, Heidl S, Hess M, et al
Vaccination with a fowl adenovirus chimeric fiber protein (crecFib-4/11) simultaneously protects chickens against hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH).
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00116.
PubMed Abstract available

SCHALTZ-BUCHHOLZER F, Toldi G
The association between parental and neonatal BCG vaccination and neonatal T helper 17 cell expansion.
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00128.
PubMed Abstract available

CARLOW DA, Lai JCY, Kollmann TR, Sadarangani M, et al
Cutaneous CpG adjuvant conditioning to enhance vaccine responses.
Vaccine. 2022 Feb 8. pii: S0264-410X(21)01668.
PubMed Abstract available

MASUDA T, Murakami K, Sugiura K, Sakui S, et al
A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report.
Vaccine. 2022 Feb 8. pii: S0264-410X(22)00164.
PubMed Abstract available

PEREZ-RODRIGUEZ S, de la Caridad Rodriguez-Gonzalez M, Ochoa-Azze R, Climent-Ruiz Y, et al
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.
Vaccine. 2022 Feb 8. pii: S0264-410X(22)00161.
PubMed Abstract available

LADHANI SN, Campbell H, Amin-Chowdhury Z, Lucidarme J, et al
Timing of meningococcal vaccination with 4CMenB (Bexsero(R)) in children with invasive meningococcal group B (MenB) disease in England.
Vaccine. 2022 Feb 8. pii: S0264-410X(21)01618.
PubMed Abstract available

CORNISH MJ, Hedrick JA, Gabrielsen AA, Johnson AD, et al
Safety and immunogenicity of an investigational quadrivalent meningococcal tetanus toxoid conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in infants and toddlers: A Phase II study.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00096.
PubMed Abstract available

DENG JZ, Lancaster C, Winters MA, Phillips KM, et al
Multi-attribute characterization of pneumococcal conjugate vaccine by Size-exclusion chromatography coupled with UV-MALS-RI detections.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00076.
PubMed Abstract available

WALKER B, Anderson A, Stoecker C, Shao Y, et al
COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid.
Vaccine. 2022;40:837-840.
PubMed Abstract available

CRUVINEL E, P Richter K, S Scheuermann T, M Machado N, et al
The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trial.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00120.
PubMed Abstract available

MEWHIRTER J, Sagir M, Sanders R
Towards a predictive model of COVID-19 vaccine hesitancy among American adults.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00134.
PubMed Abstract available

DOMNICH A, Orsi A, Sticchi L, Panatto D, et al
Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00137.
PubMed Abstract available

BELLOS I, Karageorgiou V, Viskin D
Myocarditis following mRNA Covid-19 vaccination: A pooled analysis.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00140.
PubMed Abstract available

SPRENGHOLZ P, Korn L, Eitze S, Felgendreff L, et al
Attitude toward a mandatory COVID-19 vaccination policy and its determinants: Evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00130.
PubMed Abstract available

WONODI C, Obi-Jeff C, Adewumi F, Keluo-Udeke SC, et al
Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00126.
PubMed Abstract available

WALKER J, Paul P, Dooling K, Oliver S, et al
Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00136.
PubMed Abstract available

HU S, Logan N, Puenpa J, Wanlapakorn N, et al
Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants.
Vaccine. 2022 Feb 5. pii: S0264-410X(22)00095.
PubMed Abstract available

AKGUN O, Kayaalp GK, Demirkan FG, Cakmak F, et al
Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey.
Vaccine. 2022 Feb 4. pii: S0264-410X(22)00117.
PubMed Abstract available

NONVIGNON J, Owusu R, Asare B, Adjagba A, et al
Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool.
Vaccine. 2022 Feb 4. pii: S0264-410X(22)00070.
PubMed Abstract available

OLIANI F, Savoia A, Gallo G, Tiwana N, et al
Italy's rollout of COVID-19 vaccinations: The crucial contribution of the first experimental mass vaccination site in Lombardy.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00115.
PubMed Abstract available

GORSE GJ, Grimes S, Buck H, Mulla H, et al
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00059.
PubMed Abstract available

IRVING SA, Groom HC, Dandamudi P, Daley MF, et al
A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00091.
PubMed Abstract available

TAKESHITA K, Ishiwada N, Takeuchi N, Ohkusu M, et al
Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00102.
PubMed Abstract available

GORSE GJ, Grimes S, Buck H, Mulla H, et al
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00058.
PubMed Abstract available

ELLITHORPE ME, Alade F, Adams RB, Nowak GJ, et al
Looking ahead: Caregivers' COVID-19 vaccination intention for children 5 years old and younger using the health belief model.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00097.
PubMed Abstract available

HEYERDAHL LW, Vray M, Lana B, Tvardik N, et al
Conditionality of COVID-19 vaccine acceptance in European countries.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00099.
PubMed Abstract available

SHAW J, Anderson KB, Fabi RE, Thompson CA, et al
COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00100.
PubMed Abstract available

YOUSAF M, Hassan Raza S, Mahmood N, Core R, et al
Immunity debt or vaccination crisis? A multi-method evidence on vaccine acceptance and media framing for emerging COVID-19 variants.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00101.
PubMed Abstract available

January 2022

YANG YL, Kim J, Jeong Y, Jang YS, et al
Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection.
Vaccine. 2022;40:714-725.
PubMed Abstract available

JANSSEN YF, Feitsma EA, Boersma HH, Alleva DG, et al
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00077.
PubMed Abstract available

PANWAR K, Godi A, Cocuzza CE, Andrews N, et al
Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix(R) or Gardasil(R) vaccine.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00075.
PubMed Abstract available

SANDMANN FG, van Leeuwen E, Bernard-Stoecklin S, Casado I, et al
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00039.
PubMed Abstract available

PITTET LF, Cox L, Freyne B, Germano S, et al
Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner.
Vaccine. 2022 Jan 29. pii: S0264-410X(22)00020.
PubMed Abstract available

MORGAN C, Giattas MR, Holroyd T, Pfitzer A, et al
Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence.
Vaccine. 2022 Jan 29. pii: S0264-410X(21)01674.
PubMed Abstract available

SHERIDAN S, McIntyre P, Liu B, Fathima P, et al
Pertussis burden and acellular pertussis vaccine effectiveness in high risk children.
Vaccine. 2022 Jan 28. pii: S0264-410X(21)01322.
PubMed Abstract available

MSUSA KP, Rogalski-Salter T, Mandi H, Clemens R, et al
Critical success factors for conducting human challenge trials for vaccine development in low- and middle-income countries.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00072.
PubMed Abstract available

KANTELE A, Rombo L, Vene S, Kundi M, et al
Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00048.
PubMed Abstract available

KALNIN KV, Plitnik T, Kishko M, Huang D, et al
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00045.
PubMed Abstract available

WHITE AA, Neelon B, Martin RH, Cartmell KB, et al
Spatial patterns of HPV and Tdap vaccine dose administration and the association of health department clinic access in Georgia counties.
Vaccine. 2022 Jan 28. pii: S0264-410X(21)01647.
PubMed Abstract available

DING H, Huang J, Ngai CH, Sun Q, et al
The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00057.
PubMed Abstract available

STEPPERT P, Mosor M, Stanek L, Burgstaller D, et al
A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine.
Vaccine. 2022 Jan 27. pii: S0264-410X(22)00019.
PubMed Abstract available

HE Q, Xiao J, Liu M, Li Z, et al
Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China.
Vaccine. 2022 Jan 27. pii: S0264-410X(21)01200.
PubMed Abstract available

JAFFE AE, Graupensperger S, Blayney JA, Duckworth JC, et al
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies.
Vaccine. 2022 Jan 26. pii: S0264-410X(22)00073.
PubMed Abstract available

KARAFILLAKIS E, Peretti-Watel P, Verger P, Chantler T, et al
'I trust them because my mum trusts them': Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France.
Vaccine. 2022 Jan 25. pii: S0264-410X(22)00046.
PubMed Abstract available

IANNINO F, Uriza PJ, Duarte CM, Pepe MV, et al
Development of a Salmonella-based oral vaccine to control intestinal colonization of Shiga-toxin-producing Escherichia coli (STEC) in animals.
Vaccine. 2022 Jan 24. pii: S0264-410X(22)00056.
PubMed Abstract available

OGUTI B, Ali A, Andrews N, Barug D, et al
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis.
Vaccine. 2022;40:450-458.
PubMed Abstract available

ZINTGRAFF J, Gagetti P, Napoli D, Sanchez Eluchans N, et al
Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance.
Vaccine. 2022;40:459-470.
PubMed Abstract available

BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.
Vaccine. 2022;40:536-543.
PubMed Abstract available

KIMOTO T
Development of a safe and effective novel synthetic mucosal adjuvant SF-10 derived from physiological metabolic pathways and function of human pulmonary surfactant.
Vaccine. 2022;40:544-553.
PubMed Abstract available

TANGUAY M, Boutin M, Laumaea A, Salaciak M, et al
B-cell cytopenia and time to last B-cell-depleting therapy predict response to SARS-COV-2 vaccines in patients with lymphoproliferative disorders.
Vaccine. 2022 Jan 24. pii: S0264-410X(22)00071.
PubMed Abstract available

TRICOU V, Gottardo R, Egan MA, Clement F, et al
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00040.
PubMed Abstract available

HIDALGO-RUIZ M, Mejia-Lopez S, Perez-Serrano RM, Zaldivar-Lelo de Larrea G, et al
Babesia bovis AMA-1, MSA-2c and RAP-1 contain conserved B and T-cell epitopes, which generate neutralizing antibodies and a long-lasting Th1 immune response in vaccinated cattle.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00049.
PubMed Abstract available

GHASWALLA PK, Bengtson LGS, Marshall GS, Buikema AR, et al
Corrigendum to 'Meningococcal vaccination in patients with newly diagnosed asplenia in the United States' [Vaccine 39 (2021) 272-281].
Vaccine. 2022 Jan 22. pii: S0264-410X(21)00994.
PubMed

TRENT MJ, Salmon DA, MacIntyre CR
Predictors of pneumococcal vaccination among Australian adults at high risk of pneumococcal disease.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00026.
PubMed Abstract available

STEBBINGS R, Armour G, Pettis V, Goodman J, et al
AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice.
Vaccine. 2022;40:192-195.
PubMed Abstract available

DRAZAN D, Czajka H, Maguire JD, Pregaldien JL, et al
A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adults.
Vaccine. 2022;40:351-358.
PubMed Abstract available

RUSTANDI RR, Xu Q
Reactivity characterization of bromoacetyl derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB(R) by NMR spectroscopy.
Vaccine. 2022;40:187-191.
PubMed Abstract available

TUN ZM, Ring Z, Tam CC
Factors associated with maternal tetanus vaccination in Myanmar: An analysis of demographic and health survey data.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00042.
PubMed Abstract available

LIU F, Feng C, Xu S, Wu Q, et al
An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00054.
PubMed Abstract available

LIAO Q, Cowling BJ, Xiao J, Yuan J, et al
Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00055.
PubMed Abstract available

LI LL, Zheng C, La J, Do NV, et al
Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00051.
PubMed Abstract available

PITCOVSKI J, Gruzdev N, Abzach A, Katz C, et al
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00050.
PubMed Abstract available

ZHU D, Lv M, Bai Y, Wu J, et al
Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in Beijing: A modeling analysis.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00024.
PubMed Abstract available

PASSARETTI CL, Priem JS, Agner TG, McCurdy L, et al
Reducing the rates of household transmission: The impact of COVID-19 vaccination in healthcare workers with a known household exposure.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00044.
PubMed Abstract available

TUSE D, Malm M, Tamminen K, Diessner A, et al
Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plants.
Vaccine. 2022 Jan 18. pii: S0264-410X(22)00022.
PubMed Abstract available

ROLFES L, Harmark L, Kant A, van Balveren L, et al
COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes.
Vaccine. 2022 Jan 17. pii: S0264-410X(22)00028.
PubMed Abstract available

OHFUJI S, Tanaka T, Nakano T, Kase T, et al
Annual trends in adverse events following mumps vaccination in Japan: A retrospective study.
Vaccine. 2022 Jan 17. pii: S0264-410X(22)00023.
PubMed Abstract available

BEDSTON S, Akbari A, Jarvis CI, Lowthian E, et al
COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales.
Vaccine. 2022 Jan 15. pii: S0264-410X(21)01535.
PubMed Abstract available

TANAKA M, Okubo R, Hoshi SL, Ishikawa N, et al
Cost-effectiveness of pertussis booster vaccination for preschool children in Japan.
Vaccine. 2022 Jan 13. pii: S0264-410X(22)00003.
PubMed Abstract available

SIMON JK, Staerke NB, Hemming-Harlo M, Layle S, et al
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged >/=50 years: A randomized phase 3 trial (PNEU-TRUE).
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01675.
PubMed Abstract available

MALTER KB, Tugel ME, Gil-Rodriguez M, Guardia G, et al
Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States.
Vaccine. 2022 Jan 13. pii: S0264-410X(22)00006.
PubMed Abstract available

WARNER EL, Barbati JL, Duncan KL, Yan K, et al
Vaccine misinformation types and properties in Russian troll tweets.
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01648.
PubMed Abstract available

MOYO P, Bosco E, Bardenheier BH, Rivera-Hernandez M, et al
Variation in influenza vaccine assessment, receipt, and refusal by the concentration of Medicare Advantage enrollees in U.S. nursing homes.
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01688.
PubMed Abstract available

WONG WHS, Leung D, Chua GT, Duque JSR, et al
Adolescents' attitudes to the COVID-19 vaccination.
Vaccine. 2022 Jan 12. pii: S0264-410X(22)00025.
PubMed Abstract available

WOO EJ, Moro PL
Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
Vaccine. 2022 Jan 11. pii: S0264-410X(22)00001.
PubMed Abstract available

SHIMIZU S, Tanaka R, Itoh E, Maekawa-Matsuura M, et al
Performance and usability evaluation of novel intradermal injection device Immucise and reanalysis of intradermal administration trials of influenza vaccine for the elderly.
Vaccine. 2022 Jan 11. pii: S0264-410X(21)01669.
PubMed Abstract available

BLYTH DM, Liang Z, Williams M, Murray CK, et al
Immune interference revisited: Impact of live-attenuated influenza vaccine prior to yellow fever vaccination.
Vaccine. 2022 Jan 11. pii: S0264-410X(21)01637.
PubMed Abstract available

DANIEL CL, Williams J, Legg R, McGowen C, et al
Factors associated with COVID-19 vaccination intentions among adults in the deep South.
Vaccine. 2022 Jan 10. pii: S0264-410X(21)01667.
PubMed Abstract available

PENG KW, Carey T, Lech P, Vandergaast R, et al
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.
Vaccine. 2022 Jan 10. pii: S0264-410X(21)01671.
PubMed Abstract available

OMER I, Rosenberg A, Sefty H, Pando R, et al
Lineage-matched versus mismatched influenza B vaccine effectiveness following seasons of marginal influenza B circulation.
Vaccine. 2022 Jan 8. pii: S0264-410X(21)01664.
PubMed Abstract available

VADLAMUDI NK, Patrick DM, Rose C, Sadatsafavi M, et al
A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada.
Vaccine. 2022 Jan 7. pii: S0264-410X(21)01673.
PubMed Abstract available

FOO D, Sarna M, Pereira G, Moore HC, et al
Longitudinal, population-based cohort study of prenatal influenza vaccination and influenza infection in childhood.
Vaccine. 2022 Jan 7. pii: S0264-410X(21)01556.
PubMed Abstract available

UWAMINO Y, Kurafuji T, Sato Y, Tomita Y, et al
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and universit
Vaccine. 2022 Jan 7. pii: S0264-410X(22)00002.
PubMed Abstract available

HSIAO A, Hansen J, Nunley KV, Lewis N, et al
Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational study.
Vaccine. 2022 Jan 6. pii: S0264-410X(21)01641.
PubMed Abstract available

EUSER S, Kroese FM, Derks M, de Bruin M, et al
Understanding COVID-19 vaccination willingness among youth: A survey study in the Netherlands.
Vaccine. 2022 Jan 5. pii: S0264-410X(21)01670.
PubMed Abstract available

HUANG Z, Ji M, Ren J, Sun X, et al
Effect of the framing of HPV vaccination on parents' willingness to accept an HPV vaccine.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01659.
PubMed Abstract available

GLADSTONE RA, Siira L, Brynildsrud OB, Vestrheim DF, et al
International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01377.
PubMed Abstract available

LEDLIE S, Ricci C, Pan C, Rojas A, et al
Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01655.
PubMed Abstract available

VILLENA R, Valenzuela MT, Bastias M, Santolaya ME, et al
Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01549.
PubMed Abstract available

PENLINGTON M, Goulet P, Metcalfe B
Improving knowledge and trust in vaccines: A survey-based assessment of the potential of the European Union Clinical Trial Regulation No 536/2014 plain language summary to increase health literacy.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01653.
PubMed Abstract available

ZHANG J, Ji Y, Wang Z, Jia Y, et al
Effective improvements to the live-attenuated Newcastle disease virus vaccine by polyethylenimine-based biomimetic silicification.
Vaccine. 2022 Jan 3. pii: S0264-410X(21)01662.
PubMed Abstract available

KUZNETSOVA A, Ceregido MA, Jourquin A, Campora L, et al
Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine.
Vaccine. 2022 Jan 3. pii: S0264-410X(21)01658.
PubMed Abstract available

OHM M, Knol MJ, Vos ERA, Bogaard MJM, et al
Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020.
Vaccine. 2022;40:59-66.
PubMed Abstract available

KUJAWSKI SA, Yao L, Wang HE, Carias C, et al
Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis.
Vaccine. 2022 Jan 1. pii: S0264-410X(21)01672.
PubMed Abstract available

December 2021

PASCHALL AV, Ozdilek A, Briner SL, Brindley MA, et al
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice.
Vaccine. 2021 Dec 31. pii: S0264-410X(21)01666.
PubMed Abstract available

GROOM HC, Crane B, Naleway AL, Weintraub E, et al
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems.
Vaccine. 2021 Dec 31. pii: S0264-410X(21)01656.
PubMed Abstract available

LUBLIN A, Katz C, Gruzdev N, Yadid I, et al
Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins.
Vaccine. 2021 Dec 30. pii: S0264-410X(21)01661.
PubMed Abstract available

SAELAND E, van der Fits L, Bolder R, Heemskerk-van der Meer M, et al
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.
Vaccine. 2021 Dec 29. pii: S0264-410X(21)01651.
PubMed Abstract available

FAINGELERNT Y, Dagan R, Givon-Lavi N, van der Beek BA, et al
The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants.
Vaccine. 2021 Dec 29. pii: S0264-410X(21)01636.
PubMed Abstract available

ASOGWA OA, de Hoog MLA, Bruijning-Verhagen PCJI
Impact of 7-valent versus 10-valent pneumococcal conjugate vaccines on primary care consultations across various age groups in the Netherlands, 5 years after the switch: A time-series analysis.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01533.
PubMed Abstract available

REIS LR, Costa-Rocha IAD, Campi-Azevedo AC, Peruhype-Magalhaes V, et al
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01638.
PubMed Abstract available

KUSI KA, Ofori EA, Akyea-Mensah K, Kyei-Baafour E, et al
Towards large-scale identification of HLA-restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01650.
PubMed Abstract available

CHOWDHURY F, Akter A, Bhuiyan TR, Tauheed I, et al
A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01623.
PubMed Abstract available

SHUKLA S, Fressin F, Un M, Coetzer H, et al
Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01657.
PubMed Abstract available

RIBEIRO SP, De Moura Mattaraia VG, Almeida RR, Valentine EJG, et al
A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01550.
PubMed Abstract available

DE KOFF EM, van Houten MA, de Heij F, Berbers GAM, et al
Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01622.
PubMed Abstract available

FREEMAN RE, Thaker J, Daley MF, Glanz JM, et al
Vaccine timeliness and prevalence of undervaccination patterns in children ages 0-19 months, U.S., National immunization Survey-Child 2017.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01645.
PubMed Abstract available

JUNE CHOE Y, Yi S, Hwang I, Kim J, et al
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01654.
PubMed Abstract available

THOMAS SJ, Perez JL, Lockhart SP, Hariharan S, et al
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01652.
PubMed Abstract available

LACY J, Tessier E, Andrews N, White J, et al
Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: An ecological study among London children, 2012-2018.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01619.
PubMed Abstract available

BRENNAN T, Hidle A, Doshi RH, An Q, et al
Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01531.
PubMed Abstract available

RAHIM S, Ahmad Z, Abdul-Ghafar J
The polio vaccination story of Pakistan.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01595.
PubMed Abstract available

FERNANDES C, Alves J, Rodrigues A, Azevedo J, et al
Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01544.
PubMed Abstract available

KIM HJ, Yun HJ, Kim J, Kym S, et al
Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01620.
PubMed Abstract available

ROMAIN-SCELLE N, Elias C, Vanhems P
COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhone-Alpes region (France): An ecological study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01644.
PubMed Abstract available

MANOMAIPIBOON A, Phumisantiphong U, Maneerit J, Chalearmchai Y, et al
Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01632.
PubMed Abstract available

KENNEDY RB, Ovsyannikova IG, Haralambieva IH, Grill DE, et al
Proteomic assessment of humoral immune responses in smallpox vaccine recipients.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01642.
PubMed Abstract available

PORTH JM, Wagner AL, Treleaven E, Fleischer NL, et al
Childhood vaccination timeliness following maternal migration to an informal urban settlement in Kenya.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01625.
PubMed Abstract available

TADAKUMA K, Maruyama T, Mori K, Fujiki N, et al
Effectiveness of seasonal influenza vaccine in adult Japanese workers, 2017-2020.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01624.
PubMed Abstract available

ERBER W, Khan F, Zavadska D, Freimane Z, et al
Effectiveness of TBE vaccination in southern Germany and Latvia.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01639.
PubMed Abstract available

PETERSEN MB, Jorgensen F, Lindholt MF
Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic?
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01631.
PubMed Abstract available

WILLIAMS KV, Zhai B, Alcorn JF, Patricia Nowalk M, et al
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01643.
PubMed Abstract available

SHAPIRO GK, Gottfredson N, Leask J, Wiley K, et al
COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01649.
PubMed Abstract available

BLANCO S, Salome Konigheim B, Diaz A, Spinsanti L, et al
Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort.
Vaccine. 2021 Dec 20. pii: S0264-410X(21)01634.
PubMed Abstract available

NASREEN S, Wang J, Kwong JC, Crowcroft NS, et al
Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) study.
Vaccine. 2021;39:7545-7553.
PubMed Abstract available

IVANOVA-MARKOVA Y, Gonzalez-Dominguez A, Hidalgo A, Sanchez R, et al
Cost of illness of invasive meningococcal disease caused by serogroup B Neisseria meningitidis in Spain.
Vaccine. 2021;39:7646-7654.
PubMed Abstract available

RANADE D, Jena R, Sancheti S, Deore V, et al
Rapid, high throughput protein estimation method for saponin and alhydrogel adjuvanted R21 VLP Malaria vaccine based on intrinsic fluorescence.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01627.
PubMed Abstract available

HERRING WL, Zhang Y, Shinde V, Stoddard J, et al
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01609.
PubMed Abstract available

POUKKA E, Baum U, Palmu AA, Lehtonen TO, et al
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01640.
PubMed Abstract available

WIDGREN K, Tomba GS, Leung KY, Giesecke J, et al
Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
Vaccine. 2021 Dec 17. pii: S0264-410X(21)01537.
PubMed Abstract available

CHUNG NH, Chen YC, Yang SJ, Lin YC, et al
Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.
Vaccine. 2021 Dec 17. pii: S0264-410X(21)01635.
PubMed Abstract available

CARLSON SJ, McKenzie L, Roberts L, Blyth CC, et al
Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation.
Vaccine. 2021 Dec 16. pii: S0264-410X(21)01629.
PubMed Abstract available

GOLDBLATT D, Fiore-Gartland A, Johnson M, Hunt A, et al
Towards a population-based threshold of protection for COVID-19 vaccines.
Vaccine. 2021 Dec 15. pii: S0264-410X(21)01615.
PubMed Abstract available

YU Y, Jia W, Lau MMC, Lau JTF, et al
Levels and factors derived from the Health Action Process Approach of behavioral intentions to take up COVID-19 vaccination: A random population-based study.
Vaccine. 2021 Dec 15. pii: S0264-410X(21)01628.
PubMed Abstract available

CHEN X, Wang H
On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine.
Vaccine. 2021 Dec 14. pii: S0264-410X(21)01596.
PubMed Abstract available

ALMOHAYA AM, Alsubie H, Alqarni B, Alzayad B, et al
Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data.
Vaccine. 2021 Dec 13. pii: S0264-410X(21)01610.
PubMed Abstract available

KURANI S, MacLaughlin KL, Jacobson RM, St Sauver JL, et al
Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake.
Vaccine. 2021 Dec 13. pii: S0264-410X(21)01611.
PubMed Abstract available

BOTTON J, Dray-Spira R, Baricault B, Drouin J, et al
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01617.
PubMed Abstract available

COSSU D, Ruberto S, Yokoyama K, Hattori N, et al
Efficacy of BCG vaccine in animal models of neurological disorders.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01613.
PubMed Abstract available

LUTRICK K, Groom H, Fowlkes AL, Groover KD, et al
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01593.
PubMed Abstract available

HSIEH YL, Rak S, SteelFisher GK, Bauhoff S, et al
Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01559.
PubMed Abstract available

OLIVEIRA-SILVA J, Reis T, Lopes C, Batista-Silva R, et al
Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01621.
PubMed Abstract available

ZHAO AR, Bishai DM
Public health spending, primary care, and perceived risk promoted vaccination against H1N1.
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01538.
PubMed Abstract available

KATZ MA, Harlev EB, Chazan B, Chowers M, et al
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01580.
PubMed Abstract available

AVILA-AGUERO ML, Camacho-Badilla K, Ulloa-Gutierrez R, Espinal-Tejada C, et al
Epidemiology of pertussis in Costa Rica and the impact of vaccination: A 58-year experience (1961-2018).
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01552.
PubMed Abstract available

KADKHODA K
Post RNA-based COVID vaccines myocarditis: Proposed mechanisms.
Vaccine. 2021 Dec 9. pii: S0264-410X(21)01594.
PubMed

ZHAO H, Li Y, Wang Z
Adverse event of Sinovac Coronavirus vaccine: Deafness.
Vaccine. 2021 Dec 9. pii: S0264-410X(21)01576.
PubMed Abstract available

HOOK SA, Hansen AP, Niesobecki SA, Meek JI, et al
Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States.
Vaccine. 2021 Dec 8. pii: S0264-410X(21)01540.
PubMed Abstract available

PEPIN J, Labbe AC, Carignan A, Parent ME, et al
Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, Canada.
Vaccine. 2021;39:7300-7307.
PubMed Abstract available

VON REYN CF
BCG versus rBCG: What is the way forward?
Vaccine. 2021;39:7319-7320.
PubMed

VAN HOOIJ A, van den Eeden SJF, Khatun M, Soren S, et al
BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.
Vaccine. 2021;39:7230-7237.
PubMed Abstract available

HEIJMENBERG I, Husain A, Sathkumara HD, Muruganandah V, et al
ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence.
Vaccine. 2021;39:7265-7276.
PubMed Abstract available

KOWALEWICZ-KULBAT M, Locht C
BCG for the prevention and treatment of allergic asthma.
Vaccine. 2021;39:7341-7352.
PubMed Abstract available

LENNON RP, Block R Jr, Schneider EC, Zephrin L, et al
Underserved population acceptance of combination influenza-COVID-19 booster vaccines.
Vaccine. 2021 Dec 7. pii: S0264-410X(21)01597.
PubMed Abstract available

MA J, Casadei E, Bruce TJ, Sepahi A, et al
Long-term efficacy of nasal vaccination against enteric red mouth (ERM) disease and infectious hematopoietic necrosis (IHN) in juvenile rainbow trout (Oncorhynchus mykiss).
Vaccine. 2021 Dec 7. pii: S0264-410X(21)01551.
PubMed Abstract available

MARGOLIS MA, Brewer NT, Boynton MH, Lafata JE, et al
Provider response and follow-up to parental declination of HPV vaccination.
Vaccine. 2021 Dec 6. pii: S0264-410X(21)01529.
PubMed Abstract available

PEREZ-VILAR S, Dores GM, Marquez PL, Ng CS, et al
Safety surveillance of meningococcal group B vaccine (Bexsero(R)), Vaccine Adverse Event Reporting System, 2015-2018.
Vaccine. 2021 Dec 6. pii: S0264-410X(21)01545.
PubMed Abstract available

SULIS G, Basta NE, Wolfson C, Kirkland SA, et al
Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA).
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01579.
PubMed Abstract available

RAW RK, Rees J, Kelly CA, Wroe C, et al
Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01577.
PubMed Abstract available

BRONSTEIN MV, Kummerfeld E, MacDonald A 3rd, Vinogradov S, et al
Willingness to vaccinate against SARS-CoV-2: The role of reasoning biases and conspiracist ideation.
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01553.
PubMed Abstract available

FACK C, Wood R, Hatherill M, Cobelens F, et al
The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01488.
PubMed Abstract available

NGUYEN AT, Arnold BF, Kennedy CJ, Mishra K, et al
Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01547.
PubMed Abstract available

IZAK M, Stoyanov E, Dezuraev K, Shinar E, et al
Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01557.
PubMed Abstract available

HERZBERG J, Vollmer T, Fischer B, Becher H, et al
SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01555.
PubMed Abstract available

YORSAENG R, Suntronwong N, Phowatthanasathian H, Assawakosri S, et al
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01560.
PubMed Abstract available

HELLE F, Moyet J, Demey B, Francois C, et al
Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01558.
PubMed Abstract available

LI S, Chen W, Shen Y, Xia J, et al
Molecular characterization of infectious bronchitis virus in Southwestern China for the protective efficacy evaluation of four live vaccine strains.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01546.
PubMed Abstract available

DUONG CH, Mueller JE, Tubert-Bitter P, Escolano S, et al
Estimation of mid-and long-term benefits and hypothetical risk of Guillain-Barre syndrome after human papillomavirus vaccination among boys in France: A simulation study.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01502.
PubMed Abstract available

WANG CH, Kung WJ, Lee CH, Lee CF, et al
High rates of colonization and antimicrobial resistance of group B streptococcus highlight the need for vaccination even after implementation of guidelines for intrapartum antibiotic prophylaxis.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01543.
PubMed Abstract available

MUNOZ-QUILES C, Lopez-Lacort M, Diez-Domingo J, Rodrigo-Casares V, et al
Human papillomavirus vaccines effectiveness to prevent genital warts: A population-based study using health system integrated databases, 2009-2017.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01536.
PubMed Abstract available

NEWALL AT, Beutels P, Tuffaha HW, Hall PS, et al
How can early stage economic evaluation help guide research for future vaccines?
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01462.
PubMed

PRICE J, Mooney J, Bain C, Bawa JT, et al
National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01443.
PubMed Abstract available

VALCKX S, Crevecoeur J, Verelst F, Vranckx M, et al
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020).
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01414.
PubMed Abstract available

EZE P, Aniebo CL, Agu UJ, Agu SA, et al
Validity of maternal recall for estimating childhood vaccination coverage - Evidence from Nigeria.
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01534.
PubMed Abstract available

WIRTZ C, Mohamed Y, Engel D, Sidibe A, et al
Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01447.
PubMed Abstract available

November 2021

ATTWELL K, Rizzi M, McKenzie L, Carlson SJ, et al
COVID-19 vaccine Mandates: An Australian attitudinal study.
Vaccine. 2021 Nov 30. pii: S0264-410X(21)01530.
PubMed Abstract available

SUGISHITA Y, Sugawara T
Effectiveness and cost-effectiveness of influenza vaccination for elderly people.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01257.
PubMed Abstract available

PORRAS C, Sampson JN, Herrero R, Gail MH, et al
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01486.
PubMed Abstract available

ZOU X, He J, Zheng J, Liang M, et al
Evaluation of effectiveness, safety and cost-benefit of the 23- valent pneumococcal capsular polysaccharide vaccine for HIV-Infected patients.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01532.
PubMed Abstract available

LAURENZ M, von Eiff C, Borchert K, Jacob C, et al
Vaccination rates and adherence in premature infants before and after pneumococcal conjugate vaccine schedule change for term infants - A claims database analysis in Germany.
Vaccine. 2021 Nov 28. pii: S0264-410X(21)01437.
PubMed Abstract available

LI H, Monslow MA, Freed DC, Chang D, et al
Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates.
Vaccine. 2021 Nov 28. pii: S0264-410X(21)01416.
PubMed Abstract available

MALTEZOU HC, Anastassopoulou C, Hatziantoniou S, Poland GA, et al
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01539.
PubMed Abstract available

CASTRO F, Pascale JM, Slocum Hewitt I, Calvo A, et al
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01504.
PubMed

SCHMITZ M, Luminet O, Klein O, Morbee S, et al
Predicting vaccine uptake during COVID-19 crisis: A motivational approach.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01542.
PubMed Abstract available

JIN P, Sun F, Liu Q, Wang Q, et al
An oral vaccine based on chitosan/aluminum adjuvant induces both local and systemic immune responses in turbot (Scophthalmus maximus).
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01396.
PubMed Abstract available

GULPINAR G, Uzun MB
Examining community pharmacists' intention to provide pharmacist-driven vaccination services: A structural equation modelling.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01499.
PubMed Abstract available

ROBERTSON JS, Loizides U, Adisa A, Lopez de la Rica Manjavacas A, et al
International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01528.
PubMed Abstract available

ENGEL D, Afeli ADJ, Morgan C, Zeck W, et al
Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01466.
PubMed Abstract available

AHMED S, Dorin F, Satter SM, Sarker AR, et al
The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh.
Vaccine. 2021;39:7082-7090.
PubMed Abstract available

CANNON K, Elder C, Young M, Scott DA, et al
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults >/=65 years of age with different prior pneumococcal vaccination.
Vaccine. 2021 Nov 25. pii: S0264-410X(21)01352.
PubMed Abstract available

KLEINWAKS G, Schmit V, Morrison J
Considering human challenge trials for tuberculosis vaccine development.
Vaccine. 2021 Nov 25. pii: S0264-410X(21)01469.
PubMed Abstract available

URUENA A, Badano MN, Bare P, Gonzalez J, et al
Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children.
Vaccine. 2021 Nov 24. pii: S0264-410X(21)01482.
PubMed Abstract available

BUCHMAN TG, Simpson SQ, Sciarretta KL, Finne KP, et al
Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries().
Vaccine. 2021 Nov 23. pii: S0264-410X(21)01461.
PubMed Abstract available

BETTENCOURT PJG, Joosten SA, Lindestam Arlehamn CS, Behr MA, et al
100 years of the Bacillus Calmette-Guerin vaccine.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01483.
PubMed

SUN P, Jani V, Johnson A, Cheng Y, et al
T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01325.
PubMed Abstract available

DINC HO, Saltoglu N, Can G, Balkan II, et al
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01507.
PubMed Abstract available

LENTZEN MP, Huebenthal V, Kaiser R, Kreppel M, et al
A retrospective analysis of social media posts pertaining to COVID-19 vaccination side effects.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01526.
PubMed Abstract available

AREGA SM, Knobel DL, Toka FN, Conan A, et al
Non-specific effects of veterinary vaccines: a systematic review.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01479.
PubMed Abstract available

HARA M, Koshida R, Nakano T
Parents' views on mumps, mumps vaccine, and the factors associated with vaccination in Japan.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01449.
PubMed Abstract available

YE K, Shi D, Zhang Z, Bian L, et al
A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01393.
PubMed Abstract available

LIN C, Tu P, Terry TC
Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01444.
PubMed Abstract available

CHEN T, Dai M, Xia S
Perceived facilitators and barriers to intentions of receiving the COVID-19 vaccines among elderly Chinese adults.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01484.
PubMed Abstract available

CAMBON L, Schwarzinger M, Alla F
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01467.
PubMed Abstract available

MUSCATELLO DJ, Nazareno AL, Turner RM, Newall AT, et al
Influenza-associated mortality in Australia, 2010 through 2019: High modelled estimates in 2017.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01464.
PubMed Abstract available

BELLIZZI S, Aidyralieva C, Al-Shaikh A, Muthu N, et al
Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01468.
PubMed

ORTEGA-SANCHEZ IR, Mott JA, Kittikraisak W, Khanthamaly V, et al
Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01445.
PubMed Abstract available

IRVING SA, Ball SW, Booth SM, Regan AK, et al
A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01463.
PubMed Abstract available

HAFNER-GIESSAUF H, Horn S, Schwantzer G, Sprenger-Mahr H, et al
Cholecalciferol supplementation to improve the hepatitis B vaccination response in hemodialysis patients: A first randomized open label pilot study (DeVitaHep).
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01474.
PubMed Abstract available

BLAIN AE, Reese HE, Marjuki H, Topaz N, et al
Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01480.
PubMed Abstract available

WANG W, Wang Y, Wang Y, Yan F, et al
Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01465.
PubMed Abstract available

NGUYEN KH, Anneser E, Toppo A, Allen JD, et al
Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults >/= 18 years, United States.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01485.
PubMed Abstract available

KITRO A, Sirikul W, Piankusol C, Rirermsoonthorn P, et al
Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand.
Vaccine. 2021 Nov 17. pii: S0264-410X(21)01476.
PubMed Abstract available

JEAN BAPTISTE AE, Bawa S, Oteri AJ, Dieng B, et al
Nationwide measles supplementary immunization activities to increase immunity levels in Nigeria.
Vaccine. 2021;39 Suppl 3:C1-C2.
PubMed

KORAVE J, Bawa S, Ageda B, Ucho A, et al
Internal displacement; an impediment to the successful implementation of planned measles supplemental activities in Nigeria, a case study of Benue State.
Vaccine. 2021;39 Suppl 3:C76-C81.
PubMed Abstract available

HOFF NA, Bratcher A, Mukadi P, Ahuka S, et al
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01404.
PubMed Abstract available

VOSS G, Jacquet JM, Tornieporth N, Kampmann B, et al
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01382.
PubMed Abstract available

VOHRA P, Chintoan-Uta C, Bremner A, Mauri M, et al
Evaluation of a Campylobacter jejuni N-glycan-ExoA glycoconjugate vaccine to reduce C. jejuni colonisation in chickens.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01434.
PubMed Abstract available

LIANG Q, Li H, Chang X, Zhang H, et al
A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7 months to 5 years old.
Vaccine. 2021;39:6947-6955.
PubMed Abstract available

BRAKEL KA, Binjawadagi B, French-Kim K, Watts M, et al
Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model.
Vaccine. 2021;39:6817-6828.
PubMed Abstract available

BOBO FT, Asante A, Woldie M, Dawson A, et al
Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01439.
PubMed Abstract available

ESPARZA J, Damaso CR
Searching for the origin of the smallpox vaccine: Edward Jenner and his little-known horsepox hypothesis.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01441.
PubMed

AMEND KL, Turnbull B, Zhou L, Marks MA, et al
Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012-2016.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01403.
PubMed Abstract available

SILAS J, Jones A, Weiss-Cohen L, Ayton P, et al
The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01472.
PubMed Abstract available

MURPHY RP, Taaffe C, Ahern E, McMahon G, et al
A meta-analysis of influenza vaccination following correspondence: Considerations for COVID-19.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01470.
PubMed Abstract available

ROGERS JH, Cox SN, Hughes JP, Link AC, et al
Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01471.
PubMed Abstract available

CHOKEPHAIBULKIT K, Puthanakit T, Bhat N, Mansouri S, et al
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
Vaccine. 2021 Nov 14. pii: S0264-410X(21)01425.
PubMed Abstract available

BURKE RM, Shih S, Hsiung CA, Yen C, et al
Impact of rotavirus vaccination on rotavirus hospitalizations in Taiwanese children.
Vaccine. 2021 Nov 14. pii: S0264-410X(21)01397.
PubMed Abstract available

REESE HE, McNamara LA, Vianzon V, Blain A, et al
Serogroup B meningococcal disease in persons previously vaccinated with a serogroup B meningococcal vaccine - United States, 2014-2019.
Vaccine. 2021 Nov 13. pii: S0264-410X(21)01438.
PubMed Abstract available

ROSENTHAL S, Cummings CL
Influence of rapid COVID-19 vaccine development on vaccine hesitancy.
Vaccine. 2021 Nov 13. pii: S0264-410X(21)01448.
PubMed Abstract available

HARMON SHE, Faour DE, MacDonald NE
Mandatory immunization and vaccine injury support programs: A survey of 28 GNN countries.
Vaccine. 2021 Nov 12. pii: S0264-410X(21)01390.
PubMed Abstract available

CHHABRIA S, Stanford FC
A long shot: The importance of needle length in vaccinating patients with obesity against COVID-19.
Vaccine. 2021 Nov 11. pii: S0264-410X(21)01442.
PubMed

VIZCARRA P, Haemmerle J, Velasco H, Velasco T, et al
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity.
Vaccine. 2021 Nov 11. pii: S0264-410X(21)01417.
PubMed Abstract available

AW R, Ashik MR, Islam AAZM, Khan I, et al
Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01432.
PubMed Abstract available

COLOMBATTI OLIVIERI MA, Moyano RD, Mon ML, Gravisaco MJ, et al
Evaluation of a virulent strain of Mycobacterium avium subsp. Paratuberculosis used as a heat-killed vaccine.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01433.
PubMed Abstract available

MCLEAN HQ, Levine MZ, King JP, Flannery B, et al
Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01415.
PubMed Abstract available

BABUADZE GG, Echanove J, Lamarre C, deLaVega MA, et al
A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01315.
PubMed Abstract available

RODRIGUES CMC, Plotkin SA
The influence of interval between doses on response to vaccines.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01381.
PubMed

RADWAN NF, Abu-Sheasha GA, Bedwani RN, Yassine OG, et al
Vaccine wastage and cost saving after multi-dose vial policy implementation in Egypt: A success story.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01400.
PubMed Abstract available

SHAH SFA, Ginossar T, Bentley JM, Zimet G, et al
Using the Theory of Planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01431.
PubMed Abstract available

SVENNERHOLM AM, Qadri F, Lundgren A, Kaim J, et al
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01389.
PubMed Abstract available

THULUVA S, Matur R, Tsa K, Gv SR, et al
A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEV(TM)) in 1-15 years-old healthy hepatitis A vaccine-naive children.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01326.
PubMed Abstract available

HOSANGADI D, Martin EK, Watson M, Bruns R, et al
Supporting use of thermostable vaccines during public health emergencies: Considerations and recommendations for the future.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01398.
PubMed

MCKINNON B, Quach C, Dube E, Tuong Nguyen C, et al
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01426.
PubMed Abstract available

WU K, Choi A, Koch M, Elbashir S, et al
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01435.
PubMed Abstract available

VILLANUEVA-UY MET, Lam HY, Aldaba JG, Uy TMZ, et al
Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01290.
PubMed Abstract available

CUEVAS-JUAREZ E, Pando-Robles V, Palomares LA
Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01383.
PubMed Abstract available

SHARUN K, Tiwari R, Saied AA, Dhama K, et al
SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01386.
PubMed Abstract available

GOODE JR, Cook P, Cuttino S, Gatewood SBS, et al
Early experience with COVID-19 vaccine in a Federally-Qualified Healthcare Center for the homeless.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01388.
PubMed

DE HAAS TDJ, Yeung KHT, Hutubessy R, van der Putten IM, et al
Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
Vaccine. 2021;39:6762-6780.
PubMed Abstract available

LAU CL, Mayfield HJ, Sinclair JE, Brown SJ, et al
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
Vaccine. 2021 Nov 4. pii: S0264-410X(21)01428.
PubMed Abstract available

SANZ-ROJO S, Jimenez-Garcia R, Lopez-de-Andres A, de Miguel-Diez J, et al
Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01392.
PubMed Abstract available

VASUDEVAN L, Ostermann J, Wang Y, Harrison SE, et al
Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01356.
PubMed Abstract available

RIBERA-CANO A, Dupont M, Houze-Cerfon CH, Houze-Cerfon V, et al
Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01429.
PubMed Abstract available

MIYA TV, Groome MJ, de Assis Rosa D
TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine.
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01384.
PubMed Abstract available

PIERRON A, Bozon F, Berceanu A, Fontan J, et al
Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01369.
PubMed Abstract available

MALTEZOU HC
Vaccination of healthcare personnel in the COVID-19 era: A call for actions.
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01427.
PubMed

CASSONE A, Cauda R
Multicomponent vaccines to fight SARS-CoV-2 variants of concern.
Vaccine. 2021 Nov 1. pii: S0264-410X(21)01402.
PubMed

WAGNER A, Jasinska J, Tomosel E, Zielinski CC, et al
Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments.
Vaccine. 2021 Nov 1. pii: S0264-410X(21)01401.
PubMed Abstract available

October 2021

LIU H, Zhou C, An J, Song Y, et al
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01399.
PubMed Abstract available

MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
PubMed Abstract available

KHOURY J, Najjar-Debbiny R, Hanna A, Jabbour A, et al
COVID-19 vaccine - Long term immune decline and breakthrough infections.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01370.
PubMed Abstract available

GORDON SF, Clothier HJ, Morgan H, Buttery JP, et al
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
Vaccine. 2021 Oct 29. pii: S0264-410X(21)01350.
PubMed Abstract available

GARCIA-GRIMSHAW M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
Vaccine. 2021 Oct 29. pii: S0264-410X(21)01391.
PubMed Abstract available

MAZUR A, Benitez S, Chuffart-Finsterwald S, La Rotta R, et al
COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.
Vaccine. 2021 Oct 28. pii: S0264-410X(21)01380.
PubMed

MARTIN S, Vanderslott S
"Any idea how fast 'It's just a mask!' can turn into 'It's just a vaccine!'": From mask mandates to vaccine mandates during the COVID-19 pandemic.
Vaccine. 2021 Oct 28. pii: S0264-410X(21)01351.
PubMed Abstract available

NOWALK MP, D'Agostino HEA, Zimmerman RK, Saul SG, et al
Agreement among sources of adult influenza vaccination in the age of immunization information systems.
Vaccine. 2021 Oct 26. pii: S0264-410X(21)01372.
PubMed Abstract available

JEON S, Kelly M, Yun J, Lee B, et al
Scalable production and immunogenicity of a cholera conjugate vaccine.
Vaccine. 2021 Oct 26. pii: S0264-410X(21)01312.
PubMed Abstract available

CAPPOZZO F, Dal Zotto A, Scollo M, Bernardini D, et al
dTap vaccination uptake during pregnancy: Pregnant women-focused and health professionals-focused predictors in the Veneto Region (Italy).
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01321.
PubMed Abstract available

HUANG J, Bai Y, Ding H, Wang B, et al
Acceptance of pneumococcal vaccination in older adults: A general population-based survey.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01344.
PubMed Abstract available

CHANTHAVANICH P, Versage E, Van Twuijver E, Hohenboken M, et al
Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01317.
PubMed Abstract available

OLANIPEKUN T, Abe T, Effoe V, Westney G, et al
Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01324.
PubMed Abstract available

OPRIESSNIG T, Rawal G, McKeen L, Filippsen Favaro P, et al
Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination.
Vaccine. 2021 Oct 24. pii: S0264-410X(21)01353.
PubMed Abstract available

LOEB M, Russell ML, Kelly-Stradiotto C, Fuller N, et al
Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01355.
PubMed Abstract available

MYAT TW, Thu HM, Tate JE, Burnett E, et al
Rotavirus infection among children under five years of age hospitalized with acute gastroenteritis in Myanmar during 2018-2020 - Multicentre surveillance before rotavirus vaccine introduction.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01323.
PubMed Abstract available

FAN X, Li X, Wan K, Zhao X, et al
Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01354.
PubMed Abstract available

SHACHOR-MEYOUHAS Y, Hussein K, Szwarcwort-Cohen M, Weissman A, et al
Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01327.
PubMed Abstract available

TRAN VN, Nguyen HA, Le TTA, Truong TT, et al
Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Vaccine. 2021;39:6485-6491.
PubMed Abstract available

ANDRADE G
Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01371.
PubMed Abstract available

SHUBITZ LF, Robb EJ, Powell DA, Bowen RA, et al
Deltacps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01349.
PubMed Abstract available

VAN BEEK LF, Langereis JD, van den Berg van Saparoea HB, Gillard J, et al
Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01313.
PubMed Abstract available

DAR SA, Kole S, Shin SM, Jeong HJ, et al
Comparative study on antigen persistence and immunoprotective efficacy of intramuscular and intraperitoneal injections of squalene - aluminium hydroxide (Sq + Al) adjuvanted viral hemorrhagic septicaemia virus vaccine in olive flounder (Paralichthys o
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01345.
PubMed Abstract available

ABU-RAYA B, Maertens K, Munoz FM, Zimmermann P, et al
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.
Vaccine. 2021;39:6545-6552.
PubMed Abstract available

FAN S, Li D, Zhao H, Yu L, et al
Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01375.
PubMed Abstract available

MAKOVITZKI A, Lerer E, Kafri Y, Adar Y, et al
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01376.
PubMed Abstract available

WANG J, Wagner AL, Chen Y, Jaime E, et al
Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01340.
PubMed Abstract available

JAMES EK, Bokemper SE, Gerber AS, Omer SB, et al
Persuasive messaging to increase COVID-19 vaccine uptake intentions.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01368.
PubMed Abstract available

NETANEL C, Ben-Aharon O, Ben-Ari Z, Chodick G, et al
Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016.
Vaccine. 2021 Oct 20. pii: S0264-410X(21)01287.
PubMed Abstract available

DANKWA EA, Donnelly CA, Brouwer AF, Zhao R, et al
Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United states.
Vaccine. 2021 Oct 19. pii: S0264-410X(21)01308.
PubMed Abstract available

KIM D, Pekgun P, Yildirim I, Keskinocak P, et al
Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01346.
PubMed Abstract available

DANG TKNS, Rivero Cabrera R, Yeung KHT, van der Putten IM, et al
Feasibility of age- and gestation-based routine universal influenza vaccines schedules for children aged 6 months - 2 years and pregnant women.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01291.
PubMed Abstract available

CHEN AT, Stacey HD, Marzok A, Singh P, et al
Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01341.
PubMed Abstract available

MAKI Y, Kashiwagi S, Kimizuka Y
Laser vaccine adjuvants: Light-augmented immune responses.
Vaccine. 2021 Oct 16. pii: S0264-410X(21)01233.
PubMed Abstract available

CHAPIN-BARDALES J, Myers T, Gee J, Shay DK, et al
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
Vaccine. 2021 Oct 16. pii: S0264-410X(21)01339.
PubMed Abstract available

ALI SAHRAIAN M, Ghadiri F, Azimi A, Naser Moghadasi A, et al
Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV.
Vaccine. 2021;39:6347-6350.
PubMed Abstract available

AYAZ S, Dibben O, Chapman D
Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
Vaccine. 2021 Oct 15. pii: S0264-410X(21)01320.
PubMed Abstract available

SILVER MC, Neumann PJ, Ma S, Kim DD, et al
Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01285.
PubMed Abstract available

MOGHNIEH R, Mekdashi R, El-Hassan S, Abdallah D, et al
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01314.
PubMed Abstract available

LALWANI SK, Ramanan PV, Sapru A, Sundaram B, et al
Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01208.
PubMed Abstract available

BUUS M, da Silva I, Nielsen S, Thysen SM, et al
Coverage and factors associated with receiving campaign polio vaccines in an urban population in Guinea-Bissau.
Vaccine. 2021 Oct 12. pii: S0264-410X(21)01150.
PubMed Abstract available

PARK WJ, Yoon YK, Kim Y, Park JS, et al
Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to DeltaVP8* protein from rotavirus.
Vaccine. 2021 Oct 9. pii: S0264-410X(21)01282.
PubMed Abstract available

MCNAY LA, Arnoczy G, Martell M, Mock P, et al
Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies.
Vaccine. 2021;39:6183-6185.
PubMed Abstract available

HART P, Farrar J
The influenza vaccines roadmap - A better future through improved influenza vaccines.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01286.
PubMed

VERBERK JDM, van Dongen JAP, van de Kassteele J, Andrews NJ, et al
Impact analysis of rotavirus vaccination in various geographic regions in Western Europe.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01262.
PubMed Abstract available

BRYDEN GM, Rockloff M, Browne M, Unsworth C, et al
Effect of contamination and purity priming on attitudes to vaccination and other health interventions: A randomised controlled experiment.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01278.
PubMed Abstract available

VANDERMEULEN C, Leroux-Roels I, Vandeleur J, Staniscia T, et al
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01283.
PubMed Abstract available

FU LY, Torres R, Caleb S, Cheng YI, et al
Vaccination coverage among young homeless children compared to US national immunization survey data.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01288.
PubMed Abstract available

MOTTELSON A, Vandeweerdt C, Atchapero M, Luong T, et al
A self-administered virtual reality intervention increases COVID-19 vaccination intention.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01311.
PubMed Abstract available

HUMBLE RM, Sell H, Dube E, MacDonald NE, et al
Canadian parents' perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01309.
PubMed Abstract available

BYRNE T, Patel P, Shrotri M, Beale S, et al
Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch).
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01281.
PubMed Abstract available

MULLER-PEBODY B, Sinnathamby MA, Warburton F, Rooney G, et al
Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01284.
PubMed Abstract available

GIERSING B, Shah N, Kristensen D, Amorij JP, et al
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)00996.
PubMed Abstract available

REIDENBERG BE, Hirsch K, Costello CM, Russo M, et al
Drive through COVID19 vaccination for developmentally disabled persons.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01279.
PubMed

MUKHERJEE N, Julian E, Torrelles JB, Svatek RS, et al
Effects of Mycobacterium bovis Calmette et Guerin (BCG) in oncotherapy: Bladder cancer and beyond.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01256.
PubMed Abstract available

ALLEVA DG, Delpero AR, Scully MM, Murikipudi S, et al
Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01294.
PubMed Abstract available

LAZAROS G, Anastassopoulou C, Hatziantoniou S, Kalos T, et al
A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01295.
PubMed Abstract available

DRAPER M, Stergiopoulos S
Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01223.
PubMed Abstract available

BRUCE YU Y, Taraban MB, Briggs KT
All vials are not the same: Potential role of vaccine quality in vaccine adverse reactions.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01280.
PubMed

VADREVU KM, Raju D, Rani S, Reddy S, et al
Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV(R)) vaccine up to 7years following primary vaccination of children<2years of age with, or without, a booster vaccination.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)00966.
PubMed Abstract available

CORCORAN KE, Scheitle CP, DiGregorio BD
Christian nationalism and COVID-19 vaccine hesitancy and uptake.
Vaccine. 2021 Oct 2. pii: S0264-410X(21)01289.
PubMed Abstract available

SRICHAN P, Thohinung U, Kodyee S, Apidechkul T, et al
Vaccine serocoverage under the expanded program on immunization among hill tribe children in Thailand: A cross-sectional study.
Vaccine. 2021 Oct 1. pii: S0264-410X(21)01264.
PubMed Abstract available

RANE MS, Rohani P, Halloran ME
Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.
Vaccine. 2021;39:6144-6150.
PubMed Abstract available

September 2021

NIEUWENHUIZEN NE, Zyla J, Zedler U, Bandermann S, et al
Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females.
Vaccine. 2021 Sep 30. pii: S0264-410X(21)01230.
PubMed Abstract available

LEWIS G, Lazzaro T, Crawford NW
Recurrent lipoatrophy following multiple vaccinations: A case study.
Vaccine. 2021 Sep 30. pii: S0264-410X(21)01237.
PubMed

KHAIMOVA R, Fischetti B, Cope R, Berkowitz L, et al
Serological response with Heplisav-B(R) in prior Hepatitis B vaccine non-responders living with HIV.
Vaccine. 2021 Sep 29. pii: S0264-410X(21)01251.
PubMed Abstract available

FRANCIS-OLIVIERO F, Bozoki S, Micsik A, Kieny MP, et al
Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01224.
PubMed Abstract available

YACOUB MR, Cucca V, Asperti C, Ramirez GA, et al
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01239.
PubMed Abstract available

ROMANO CJ, Hall C, Khodr ZG, Bukowinski AT, et al
History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01171.
PubMed Abstract available

HOFMEISTER MG, Weng MK, Thoroughman D, Thomasson ED, et al
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01254.
PubMed Abstract available

MOON JE, Greenleaf ME, Regules JA, Debois M, et al
A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01203.
PubMed Abstract available

CASEY RM, Adrien N, Badiane O, Diallo A, et al
National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01075.
PubMed Abstract available

SINGH AK, Srikrishna G, Bivalacqua TJ, Bishai WR, et al
Recombinant BCGs for tuberculosis and bladder cancer.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01231.
PubMed Abstract available

VIEIRA REZENDE RP, Braz AS, Guimaraes MFB, Ribeiro SLE, et al
Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01260.
PubMed Abstract available

BLEICHER I, Kadour-Peero E, Sagi-Dain L, Sagi S, et al
Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01234.
PubMed Abstract available

SHEVZOV-ZEBRUN N, Caplan A
Parental consent for vaccination of minors against COVID-19.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01250.
PubMed

FISHER KA, Nguyen N, Crawford S, Fouayzi H, et al
Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01261.
PubMed Abstract available

MOLODECKY NA, Jafari H, Safdar RM, Ahmed JA, et al
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01228.
PubMed Abstract available

ZENG W, Cui Y, Jarawan E, Avila C, et al
Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01235.
PubMed Abstract available

AKSNES BN, Walldorf JA, Nkwenkeu SF, Zoma RL, et al
Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01229.
PubMed Abstract available

FADLYANA E, Rusmil K, Tarigan R, Rahmadi AR, et al
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01255.
PubMed Abstract available

SINGH AK, Phatak SR, Singh R, Bhattacharjee K, et al
Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)(R)) and BBV-152 (Covaxin(TM)(R)) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01258.
PubMed Abstract available

FOWLER A, Sampson M, Remaley AT, Chackerian B, et al
A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
Vaccine. 2021;39:5780-5786.
PubMed Abstract available

NOWAK SA, Gidengil CA, Parker AM, Matthews LJ, et al
Association among trust in health care providers, friends, and family, and vaccine hesitancy.
Vaccine. 2021;39:5737-5740.
PubMed Abstract available

YAMAZAKI Y, Ikeda M, Imada T, Furuno K, et al
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased ris
Vaccine. 2021 Sep 23. pii: S0264-410X(21)01168.
PubMed Abstract available

MOORE KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, et al
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.
Vaccine. 2021 Sep 23. pii: S0264-410X(21)01028.
PubMed Abstract available

CHOWDHURY F, Akter A, Rahman Bhuiyan T, Tauheed I, et al
A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01222.
PubMed Abstract available

MELGAARD A, Krogsgaard LW, Randrup T, Plana-Ripoll O, et al
Pre-vaccination vulnerability and suspected adverse events following HPV vaccination. A case-control study nested in the Danish national birth cohort.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01232.
PubMed Abstract available

LIU CH, Huang WT, Chie WC, Arnold Chan K, et al
Safety surveillance of varicella vaccine using tree-temporal scan analysis.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01226.
PubMed Abstract available

GIESE H, Neth H, Gaissmaier W
Determinants of information diffusion in online communication on vaccination: The benefits of visual displays.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01195.
PubMed Abstract available

ANGSUWATCHARAKON P, Puthanakit T, Bunjoungmanee P, Anugulruengkitt S, et al
High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
Vaccine. 2021 Sep 20. pii: S0264-410X(21)01127.
PubMed Abstract available

MANSUY JM, Sagna AS, Laurent M, Izopet J, et al
COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination?
Vaccine. 2021 Sep 17. pii: S0264-410X(21)01227.
PubMed

MOSINA L, Kulper-Schiek W, Jacques-Carroll L, Earnshaw A, et al
Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)01225.
PubMed Abstract available

PRESTON KB, Wong TAS, To A, Tashiro TE, et al
Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.
Vaccine. 2021;39:5650-5657.
PubMed Abstract available

LI L, Hessell AJ, Kong XP, Haigwood NL, et al
A large repertoire of B cell lineages targeting one cluster of epitopes in a vaccinated rhesus macaque.
Vaccine. 2021;39:5607-5614.
PubMed Abstract available

SULIMAN DM, Nawaz FA, Mohanan P, Modber MAKA, et al
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01194.
PubMed Abstract available

August 2021

LAMM DL, Morales A
A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment.
Vaccine. 2021 Aug 17. pii: S0264-410X(21)01046.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: